Hi guys, I know that Protein structure related to their function. Certain protein usually have alpha helix is more prominent but certain protein have beta structure more prominent. My question is which aminoacid is favourable to form alpha helix and beta structure? What function unique to alpha helix and beta structure?

Shire UK is a biopharmaceutical firm founded in 1986 that develops pharmaceutical drugs by working in close conjugation with nurses, doctors, health professionals and pharmacists. The firm develops pharmaceutical products for various life threatening diseases such as Alzheimer’s disease, ADHD – Attention deficit Hyperactivity Disorder, fabry disease, ulcerative colitis, constipation, essential thrombocythaemia, Hunter syndrome, chronic kidney disorder, Gaucher’s disease and heredity angioedema. Shire UK functions with the mission of developing drugs that would help individuals lead a healthy life.
The firm’s product is marketed in about 50 countries and it has offices across 29 countries globally with employee strength of more than 5,300.
Popular biotech products


Shire UK produces and develops pharmaceutical products for the following disease areas:
• Neuroscience
• Rare diseases
• Gastrointestinal disorders
• Regenerative medicine and
• Internal medicines

It develops products with the view that they can help patients with life threatening disease conditions lead better and comfortable lives. The following is a list of products that has been developed by this firm:
• Adderall XR
• Agrylin
• Alertec
• Calcichew
• Carbatrol
• Dermagraft
• Elaprase
• Elvanse
• Equasym XL
• Estrace
• Exputex
• Firazyr
• Fosrenol
• Foznol
• Intuniv
• Lialda
• Mezavant
• Mezavant XL
• Midon
• Mintec
• Pentasa
• Proamatine
• Reminyl
• Replagal
• Resolor
• Vpriv
• Vyvanse
• Xagrid

Latest discoveries
The product pipeline of Shire pharmaceuticals is loaded with several new and innovative products to combat various disease conditions. Of the several products that have been listed below many are in the phase 3 of clinical trials and the rest are in the phase 2. Below is the list:
• SPD 555 for chronic constipation
• SPD 557 for gastroesophageal reflux
• ABH 001 for epidermolysis bullosa
• SRM 003 for acute vascular repair
• SPD 606 for dry eye disease
• SPD 602 for chronic iron over load
• HGT – ROP – 001 for retinopathy prematurity

Recent company takeovers
Shire UK recognizes the importance of collaborations and partnerships that would widen the research areas and also help expand the business prospects. The following list speaks of some of the recent acquisitions in the year 2013 by this firm:
• The firm acquired Sarcode, a biopharmaceutical firm based in California. This collaboration strengthened Shires’s research in the ophthalmologic area.
• Shire joined hands with Premacure AB in the current year. This collaboration caused the development of a protein replacement therapy that is used for prevention of premature retinopathy.
• Early in this year, Shire acquired Lotus tissue repair. This collaboration lead to the development of protein replacement therapy for treatment of epidermolysis bullosa.
• The firm also acquired Ethris GmbH and both the companies announced a research based alliance for development of novel – RNS based therapeutics. This can be used for treatment of several monogenic genetic diseases.

Work culture
Brave - is the word to define the work culture at Shire which has a dynamic environment. The firm is mission driven and believes in creating products that would help individuals with deadly diseases to lead better lives. The firm has operations worldwide and is ever ready to hire aspirant individuals who are willing to take the company to greater heights.
The working environment of this firm is truly positive that gives each employee his own space to research, experiment and grow. The employees at Shire enjoy number of benefits; some of which includes health insurance, flexible spending accounts, disability benefits, paid time off, employee assistance program, healthy lifestyle reimbursement, educational assistance, employee stock purchase plan, employee referral incentives, adoption assistance and the 401 (K) plan.

Interesting events
The firm is always in the public eye due its constant innovations and developments in the field of pharmacy. The year 2013 has indeed been an eventful year for this firm and the following list will prove the above mentioned fact.
• Shire will present at the Morgan Stanley Global Health Conference and the Bank of America Merrill Lynch Global Health Conference.
• In the mid of this year, the firm announced the launch of educational resource materials for individuals with diabetes.
• The firm also announced scholarship awards for individuals with ADHD.
• The drug named Vyanse got approval in the US for treatment of children and adolescents with ADHD.
• Earlier this year, the firm received approval in UK for yet another drug– Elvanse for treatment of children and adolescents with ADHD.

Recent job openings
The following is a list of job openings at Shire pharmaceuticals.
• Director, Pharmacovigilance and Risk management – id: 6348BR: In this, the individual will have the primary responsibility of managing the therapeutic division. The candidates need to have a post graduate degree and past experience in the relevant field.
• Controlled substance manager – id: 6360BR: The individual is responsible for managing the manufacturing, packaging, distribution and a warehouse site of the firm’s outsourcing business areas. The candidates should have past experience in handling DEA audits and inspections. Candidates interested in applying for this position should hold a graduate degree with past experience in relevant field.
• Associate Director, Controlled Substance Management – id: 6362BR: The individual will work directly with the outsourcing department of this firm. He is also responsible for providing appropriate support for conducting data analysis.
• Associate director, Risk management – id: 6350BR: In this, the individual will be responsible for reporting directly to the senior director of risk management. His responsibilities will include coordination, contribution and facilitation of plans related to risk management. The candidate should have past experience in pharmacy field and should be a graduate at the minimum.
• Director Compliance – id: 6154BR: In this, the individual will have to assist the vice president of compliance. This is an altogether newly created position in this firm and interested candidates should preferably be a law graduate with experience in implementation in commercial compliance programs.
• Director, Medical writing – id: 6065BR: The individual will be responsible for medical writing of the business projects. He would also be accountable for creating the marketing objectives of business proposals. The candidate should hold a doctorate degree in the relevant field.
• Senior Sales Analytics and reporting analyst – id: 6171BR: The individual will be responsible for the development and support of Veeva CRM solutions. The candidates should hold a graduate or equivalent degree in relevant field and should have experience in pharmaceutical industry.

Hospira is a global US based pharmaceutical company that has its headquarters in Lake Forest, Illinois. The firm is also involved in manufacturing medical devices and is driven by the mission of “advancing wellness”. It has about 15,000 employees and is considered as the world’s largest manufacturer of generic injectable pharmaceuticals.
Long back, Hospira was a division of Abbott Laboratories and later on it moved out to function as an independent company. The products developed by this firm are used by the hospitals, home – care health providers, long term care facilities and clinics. Hospira is a member of NYSE and is traded as HSP.



Popular biotech products
As already stated, Hospira is the largest producer of pharmaceuticals and medical devices. This explains that the list of products for both medical devices and pharmaceutical products would be endless. The following list will speak of some of the most popular and important products developed by this firm.
• Azithromycin
• Biosimilars
• Bupivacaine
• Cefazolin
• Claforan
• Clindamycin
• Dobutamine
• Erythropoietin
• Filgrastim
• Gentamicin
• Heparin
• Irinotecan
• Morphine
• Ondasetron
• Precedex
• Propofol
• Topotecan
• Vancomycin
• Zantac

The firm also produces medical devices for hospital and other similar health care centers. These are:
• Gemstar Sp
• Hospira Mednet software
• Lifecare PCA
• LIfeshield
• Plum A+
• Symbiq – an infusion system
• TheraDoc

Latest discoveries
Hospira is constantly at par with the latest innovations and developments taking place in the medical field. It is also involved in various development programs and produces latest products that are of benefit for the world at large.

Inflectra – is the first biosimilar monoclonal antibody developed by this firm to have received approval in Europe. This drug is indicated for treatment of rheumatoid arthritis, plaque psoriasis and inflammatory bowel disorders.

Recent company takeovers
Hospira was earlier a division of Abbott Laboratories and later on in the year 2004 it took off to be an independent firm. The firm recognizes the importance of collaborations and partnerships with various firms for expanding their business and research areas. The following is a list of collaborations that have taken place recently:

Collaborations
• In the year 2007, the firm purchased Mayne Pharma Ltd., for $2.1 billion. Mayne is an Australian based firm and specializes in injectables. This collaboration widened Hospira’s international reach and also extended its research into the field of oncology.
• In the year 2009, Hospira collaborated with an Indian pharmaceutical firm named Pliva – Croatia. This collaboration was worth $400 million and widened the parent company’s reach in generic injectable pharmaceuticals. In the same year, the firm also joined hands with TheraDoc which is a clinical informatics company.
• The next year, 2010 also witnessed the partnership of Hospira with Javelin pharmaceuticals at $145 million.

Recent corporate news
The worldwide sales of Hospira in the year 2011 was recorded to be $ 4.1 billion.

Work culture
The work culture at Hospira is very positive and at the same time dynamic. It considers its employees as its assets and hands out monetary benefits and awards to them for their exemplary performance. The firm has several programs and health and medical benefits for its employees. These consist of Health Reimbursement Account (HRA), Health Savings Account (HAS), generously matched 401 (K) retirement savings plan, and plans for supporting the development and education programs.

Interesting events
Hospira with its constant efforts to carry out top quality research for developing world class pharmaceutical products and medical devices is always in the news. The current year has several upcoming interesting events. These are as follows:
• The firm will present at the Morgan Stanley Global Health Conference
• Hospira announces the first and second quarter financial results.
• The firm obtained exclusivity for one its products named Precedex meant for pediatrics.
• In the current year, the firm signed an International Distribution Agreement with Q Core for sapphire Infusion System.
• Hospira would also present its results and findings in upcoming conferences.
• Earlier in this year, the firm’s TheraDoc Infection Control Assistant was ranked number 1 in the KLAS report.

Recent job openings
Hospira is forever on the hunt for young and experienced individuals to join them in their research and develop new innovative products for the world at large. Following is a list of job openings available with this firm:
• Manager, Regulatory affairs, Medical Device: The individual is responsible for implementing the strategies and listing down the priorities. He should also be competent enough to analyze the risks as well as the benefits in developing strategies for manufacturing medical devices. For applying for this position, the individual should hold at least a bachelors degree in life science, but a master degree holder will be given preference.
• Director, Program management: The individual will be responsible for ensuring on time delivery of the multiple programs for development of new products and would also be accountable for architecting of the products. For applying for this job opening, the individual should have more than 10 years of experience in industry and should also have strong leadership skills.
• Director, Global safety Operations: In this, the individual will have to lead a team of analysts and is responsible for the quality as well as on time delivery of the devices for FDA regulatory reports. Candidates applying for this job should have a bachelor’s degree in health or technical field. The individual should also have a minimum of 5 years of experience in health care environment and should also possess knowledge of FDA regulated business.
• Senior manager, Global inspections: In this the individual will have to directly work at the manufacturing sites to inspect the entire manufacturing process of the products. He would also be responsible for development and implementation of global strategies and global model for an effective internal audit program. Candidates who wish to apply for this position should have a minimum of 7 – 10 years of industrial experience and should posses’ strong influential skills to convince the stakeholders.
• Principal engineer: In this the individual will function as an important team member in the R&D department. The candidates should have 10 – 15 years of experience in Engineering or should also have 4 – 8 years in MS.

Basic Information:
Purdue University, located in West Lafayette, Indiana, is the flagship university of the six-campus Purdue University system. Purdue was founded on May 6, 1869, as a land-grant university when the Indiana General Assembly, taking advantage of the Morrill Act, accepted a donation of land and money from Lafayette businessman John Purdue to establish a college of science, technology, and agriculture in his name. The first classes were held on September 16, 1874, with six instructors and 39 students. Today, Purdue is a member of the Big Ten Conference, and is a well known world-class research institution. Purdue enrolls the second largest student body of any university in Indiana as well as the fourth largest international student population of any university in the United States.

Purdue offers both undergraduate and graduate programs in over 211 major areas of study, and is well known for its competitive engineering curricula. The university has also been highly influential in America's history of aviation, having established the first college credit offered in flight training, the first four-year bachelor's degree in aviation, and the first university airport (Purdue University Airport). Purdue's aviation technology program remains one of the most competitive aviation-specific programs in the world. In the mid-20th century, Purdue's aviation program expanded to encompass advanced spaceflight technology giving rise to Purdue's nickname, Cradle of Astronauts. Twenty-three Purdue graduates have gone on to become astronauts, including Gus Grissom (one of the original Mercury Seven astronauts), Neil Armstrong (the first person to walk on the moon), and Eugene Cernan (the most recent person to walk on the moon).



Undergraduate Programs:
The Weldon School of Biomedical Engineering offers an undergraduate program in Biomedical Engineering. Training to be a Purdue biomedical engineer requires engineering science, analysis, and design knowledge and skills applied within the context of biological and medical conditions in order to improve human health. Students enjoy the contemporary, state-of-the-art building that houses BME undergraduate classrooms and research laboratories, media rooms, and faculty, staff, and student services offices.

The world has tremendous need for solutions to problems related to the environment, energy, health, food, and sustainability. Biological systems are related to or at the heart of all of these issues. A biological engineer learns to design and analyze biological systems to develop innovative and practical solutions. B.S. graduates are well prepared for careers in the food industry, pharmaceutical industry, biotechnology, and bioprocessing as well as entrance into graduate or medical school. Students may select a major and plan of study within biological engineering that is tailored to their specific career goals. The areas of focus include: Bioprocess engineering and bioenergy engineering; Cellular and biomolecular engineering; Food process engineering; and Pharmaceutical process engineering

The Department of Biological Sciences at Purdue encourages students to get involved in research during their undergraduate career. Undergraduate research is one of the best things a student can do to enrich a Purdue Biology degree. It provides a strong background for classes, a chance to interact with leading researchers every day, and an invaluable understanding of how science happens.

Undergraduate tuition: $8893/year in-state; $27,061/year out-of-state. Financial aid is available in the form of scholarships, grants, loans, and work-study. Students should complete the FAFSA to be eligible for aid.

Graduate Programs:
Biomedical engineering is one of the fastest growing engineering fields, and the knowledge and skills of persons with advanced degrees are in high demand. At the Weldon School, students will find highly interdisciplinary research and teaching that spans contemporary biomedical engineering. The master’s and doctoral-level programs at Purdue University comprise faculty and laboratories from multiple entities, including the Purdue College of Engineering, College of Science, and School of Veterinary Medicine on the West Lafayette campus, as well as the Purdue School of Engineering and Technology and Indiana University School of Medicine on the Indiana University-Purdue University campus in Indianapolis. The combined faculty, staff, and facilities of the two campuses offer unparalleled resources and opportunities for graduate students.

The Purdue University Department of Agricultural and Biological Engineering is consistently ranked among the top in the nation. In fact, the graduate program has been ranked #1 by US News & World Report for the fifth consecutive year. Purdue University has master’s and PhD programs in the following areas of specialization: Agricultural and Biological Engineering; Agricultural Systems Management; Biological Engineering and Technology; Biological and Food Process Engineering; Ecological Sciences and Engineering; and Fluid Power (Engineering).

Graduate study in Biological Sciences at Purdue University is multi-disciplinary, offering a wide variety of choices for doctorate and masters degrees. Major research groups exist in the fields of Development and Disease, Ecology and Evolutionary Biology, and Molecular Biosciences. Areas of research include biology education research; cancer biology; developmental neurobiology; cell biology; ecology and conservation biology; genetics, genomics and computational biology; microbiology; molecular pathogenesis; physiology and behavior; plant biology and bioenergy; structural biology and biophysics. A major advisor may be selected in any of these areas. In addition, several interdisciplinary programs also are available in conjunction with other departments and divisions within the University. We therefore welcome applicants from different disciplines such as chemistry, physics and related fields as well as students from traditional biological backgrounds.

The path to an exciting academic or industrial career in biomedical science begins here with Purdue’s Department of Basic Medical Sciences. The Department of Basic Medical Sciences (BMS) combines the personal attention of a small department, with a unique breadth of training. BMS offers graduate study leading toward a master’s degree and a doctoral degree. The department also offers a combined degree/dual degree option for students in one the of DVM professional curriculum. BMS has active research programs in the following areas: Cancer biology; Muscolo-skeletal biomechanics and skeletal adaptation; Neural development, mechanisms of injury and regeneration; Tissue dynamic spectroscopy; and Cellular and molecular screening and high throughput analysis of cell function.

The Biomedical Sciences Interdisciplinary Graduate Program is aimed at training scientists with an interest in biomedical sciences. This interdisciplinary graduate training program is administered jointly between the School of Veterinary Medicine (SVM) and the Weldon School of Biomedical Engineering. This unique Ph.D. program fills a need for a medically-oriented program for scientists who wish to undertake careers in such areas as implantable medical devices, natural biomaterials, tissue engineered therapies, drug delivery strategies, and diagnostic sensors. This program emphasizes biomedical approaches to diagnose and treat human diseases. Two signature areas of this program are biomedical research in spinal cord injury and nanomedicine approaches to cancer and other diseases. Applicants should have at least a bachelor’s degree. The minimum requirements for GRE (preferably higher since this program is very competitive) are verbal: 550; and quantitative: 700. Applicants whose native language is not English must achieve a TOEFL score of at least 550 (paper version) or 213 (computer version) or writing-18, speaking-18, listening-14, reading-19, total-77 (Internet version). Interest in the IBSC Ph.D. track by students with backgrounds in fields such as biology, biochemistry, chemistry, biophysics, physics, computer science, and pharmaceutical sciences is anticipated and encouraged. Students interested in biomedical engineering who have undergraduate or graduate degrees in engineering should apply directly to the Biomedical Engineering Graduate Program in the Weldon School of Biomedical Engineering.

Graduate tuition: $8893/year in-state; $27,061/year out-of-state. Financial aid is available to PhD students in the form of research and teaching assistantships.

Statistics:
Applied - 29,721
Admitted - 20,318 68%
Enrolled total - 6,821
Full Time: - 6,773
Part Time - 48

Standards:
Test - 25th % - 75th %
SAT Reading - 490 - 610
SAT Math - 550 - 690
SAT Writing - 500 - 610
ACT Composite - 24 - 30
ACT English - 23 - 30
ACT Math - 24 - 31
ACT Writing - 0 - 0

Retention / Graduation:
Retention rate - 90%
4-year graduation rate - 38%
6-year graduation rate - 70%

Other Information:
Princeton Review Best Value University
Top Ten Education Technology Innovators, according to Campus Technology Magazine
14:1 Student:Teacher ratio
1st University to place a band member on the moon (Neil Armstrong)

Undergraduate Programs and Majors:
Biomedical Engineering (BS)
Biological Engineering (BS)

Graduate Programs:
Biomedical Engineering (MSE/MS/PhD)
Biological Engineering (MS/PhD)
Basic Medical Sciences
Biomedical Sciences Interdisciplinary Graduate Program (PhD)

Dual Degree Programs:
Fifth-Year Combined BS/MS in Biomedical Engineering (with Thesis)



Application Deadlines:
Undergraduate: November 1st Early Action and select programs; February 1st, Regular Admission
Students should apply using the Common Application: https://www.commonapp.org/Login
Graduate: Varies by department

Basic Information:
UIC is a major research university offering the cultural, business and entertainment opportunities you can only find in a world-class city. As one of the top 200 research-funded institutions in the world, UIC faculty members discover the things that others teach. Choose from 15 academic colleges including the UIC College of Medicine-the largest in the nation-which educates one in six Illinois physicians.

With nearly 2,574 instructional faculty members, there is one faculty member to every 11 students, which allows for a more personal learning experience. What's more, 75 percent of tenured faculty members teach undergraduate courses and 83 percent of full-time instructional faculty members have earned a PhD or equivalent.

16,911 undergrads and 10,669 graduate and professional students make up one of the most diverse student bodies in the United States. Whether living in residence halls, near campus or commuting, there's always something interesting going on, from social events, clubs, sororities and fraternities, to two state-of-the-art fitness centers, and more-not to mention everything Chicago has to offer just minutes away.



Undergraduate Programs:
The College of Engineering at UIC offers an undergraduate degree in bioengineering. The department faculty routinely includes undergraduate students in world-class bioengineering research programs, and maintains strong interactions with faculty in the Colleges of Medicine, Dentistry and Pharmacy, the Department of Biological Sciences, and other engineering disciplines. The undergraduate curriculum includes rigorous training in bioengineering fundamentals, including medical product development, complimented by significant course work in physiology, mathematics and chemistry. Each student must complete a program of required core courses and select an individualized course track in one specialized area (Neural Engineering, Cell and Tissue Engineering, or Bioinformatics) best suited to the student’s interests. The department offers several elective courses to help prepare students for a variety of career paths, including launching start-up companies or careers in industry or consulting.

The UIC Department of BioEngineering has unique resources because of its close affiliation with the clinical and research programs of the University of Illinois Medical Center at Chicago and the opportunities to intern at major biomedical manufacturers (Abbott, Baxter, Biomet, General Electric, and Siemens, for example) in the Chicago and northwest Indiana areas. Students can easily work at facilities on campus or in the adjoining Illinois Technology Park. Senior design projects, co-op assignments, or academic year internships can also be conducted in Chicagoland biomedical industries.

UIC offers a bachelor’s degree in biochemistry. It is a joint program of the Department of Biological Sciences and the Department of Chemistry. It is intended for students planning advanced study in biochemistry or molecular biology, who wish to pursue a medical degree, or who will be seeking employment and careers in biochemistry, molecular biology, biotechnology, or related fields. Students may be advised through either department.

Students can also obtain a bachelor’s of science degree in biology from the College of Liberal Arts and Sciences. The department boasts many talented faculty who teach courses and welcome undergraduates into their labs who are seeking research experience. Many affiliated faculty in colleges outside of LAS also take students into their labs. The Department of Biological Sciences is one of the largest and most active departments at UIC. Undergraduate and graduate training opportunities are offered in all major areas of biology, including molecular, cellular, and developmental biology, neuroscience, ecology, and evolution. The Guaranteed Professional Program Admissions (GPPA) Initiative ensures that qualified undergraduate applicants gain guaranteed postgraduate admission to medical school or other professional programs.

Undergraduate tuition: $9879/year in-state; $22,172/year out-of-state. Financial assistance is available in the form of scholarships, grants, loans, and work-study.

Graduate Programs:
The Graduate Education in the Medical Sciences (GEMS) program is an umbrella program for PhD students, encompassing several departments at the UIC College of Medicine. The GEMS Program offers students integrated training in the biomedical sciences. Graduate programs include the areas of Anatomy, Biochemistry, Biophysics, Cell & Molecular Biology, Genetics, Immunology, Microbiology, Neurosciences, Pathology, Pharmacology and Physiology. Students have the flexibility to choose a mentor from among more than 110 funded research faculty in all departments and PhD programs of the College of Medicine. Areas of research excellence within the broader disciplines include Cancer; Development; Gene Regulation; Host-Pathogen Biology; Lung Biology; Molecular and Integrated Cardiac and Vascular Biology; Proteomics, Genomics & Bioinformatics; Reproductive Biology; Signal Transduction; and Virology.

The Department of Biological Sciences offers graduate degrees in three program areas: Ecology and Evolution; Molecular, Cell, and Developmental Biology; and Neurobiology. Some students also participate in the interdisciplinary doctoral training program in Neuroscience.

The Graduate Program in Neuroscience at the University of Illinois at Chicago (UIC) is designed to provide in-depth training and practical research and teaching experience in fundamental life sciences leading to a Doctor of Philosophy degree in Neuroscience. The Graduate Program is not itself a Department but is an interdepartmental program directly administered by the UIC Graduate College. This interdisciplinary program brings together faculty and students from several UIC Colleges and academic disciplines whose research emphasizes cellular/molecular, systems/cognitive, and behavioral/applied approaches to the study of Neuroscience. Faculty from several Colleges and Departmental Programs participate in the Neuroscience Program. These Colleges include: College of Liberal Arts & Sciences, College of Medicine, College of Dentistry, College of Applied Health Sciences, College of Engineering, College of Nursing, and College of Pharmacy. The faculty also have strong ties to other UIC research centers, including the Laboratory of Integrative Neuroscience. Together, these scientists and clinicians advance our understanding of the brain, provide new treatments, and train the next generation of neuroscientists.

The MS and Ph.D. programs in Bioengineering provide training in the research and development of systems using engineering concepts and methods that apply modern technology to problems of living systems and health care.

Many UIC graduate programs also participate in the prestigious NIH-supported Medical Scientist Training Program (MSTP), a competetive MD/PhD program providing 7 years of support for pursuit of MD and Ph.D degrees in a coordinated seamless experience with the UIC College of Medicine, home of the largest medical school in the country.

Graduate school applicants should have a minimum undergraduate GPA of 3.0. GRE scores, letters of recommendation, and personal statements are also required.

Graduate tuition: $12,059/year in-state; $22,355/year out-of-state. PhD students are eligible for financial assistance in the form of research and teaching assistantships.

Statistics:
Applied - 14,564
Admitted - 9,151 63%
Enrolled total - 3,115
Full Time: - 3,097
Part Time - 18

Standards:
Test - 25th % -75th %
SAT Reading - 450 - 600
SAT Math - 500 - 650
SAT Writing - 480 - 610
ACT Composite - 21 - 26
ACT English - 21 - 27
ACT Math - 21 - 27
ACT Writing - 0 - 0

Retention / Graduation:
Retention rate - 79%
4-year graduation rate - 24%
6-year graduation rate - 54%

Undergraduate Programs and Majors:
Bioengineering (BS)
Biochemistry (BS)
Biology (BS)

Graduate Programs:
Anatomy (PhD)
Biochemistry (PhD)
Biophysics (PhD)
Cell and Molecular Biology (PhD)
Genetics (PhD)
Immunology (PhD)
Microbiology (PhD)
Neurosciences (PhD)
Pathology (PhD)
Pharmacology (PhD)
Physiology (PhD)
Ecology and Evolution (MS/PhD)
Molecular, Cell, and Developmental Biology (MS/PhD)
Neurobiology (MS/PhD)
Bioengineering (MS/PhD)

Dual Degree Programs:
MD/PhD
DDS/PhD
MD/MBA
MD/MPH
Guaranteed Professional Program Admission (GPPA- BS/MD or other professional degree)
BS/MS Bioinformatics


Application Deadlines:
Undergraduate: January 31st
Undergraduates should apply via the Common Application: https://www.commonapp.org/Login
Graduate: January 1st
Application is available online at: http://grad.uic.edu/cms/?pid=1000019

Basic Information:
Abraham Lincoln played a significant role in the creation of the premiere public university in his home state by signing the Morrill Act, the legislation that created the land grant university system. At the time of Lincoln's presidency, the United States was rich in land, and Congressman Justin Morrill's legislation gave states millions of acres that could be used or sold to fund state universities. In 1867, Illinois sold 380,000 of its 480,000 land grant acres at 66 cents an acre, raising a little more that $250,000 to fund Illinois Industrial University, which would become the University of Illinois.

Learning and LaborThe first regent (president) of the University was John Milton Gregory. Until Gregory's arrival, many proponents of the new university wanted it to stick to providing a mechanical and industrial education to the state's citizens, who were mostly farmers. Gregory made clear that the university would provide a "liberal and practical education to the industrial classes." In his inaugural address, Gregory stated that the university must offer "a full table spread with every form of human knowledge, and bid (students) freely to the feast." It was largely because of Gregory that the university's Alma Matercurricula was broadened to offer a range of scholarly pursuits for the first class of 77 students, and for generations of Illini.

Illinois is proud of its land grant heritage and continues to strive toward continued realization of the mission mandated with Lincoln's signature: excellence in education, research, and public engagement.


Undergraduate Programs:
The MCB undergraduate curriculum is focused on the fundamental structures, functions, and mechanisms of living organisms. The curriculum provides you with a solid foundation in biochemistry, cell and developmental biology, microbiology, molecular genetics, and physiology and structural biology. You will also develop a strong foundation in math and physical sciences. Incoming Freshmen should apply for admission to the College of Liberal Arts & Sciences (LAS) and choose Biology as your intended major. Freshmen in Biology will take an introductory course in Integrative Biology (IB) and an introductory course in Molecular and Cellular Biology (MCB). Just prior to sophomore year students will consult with an advisor and decide between Integrative Biology and Molecular and Cellular Biology for their final degree program.

Integrative biology is the study of how the different components of life interact, from molecules through global cycles. An Integrative Biology (IB) major, offered by the School of Integrative Biology, provides a solid foundation of knowledge and skills in the biological sciences by preparing students in genetics, physiology and development, behavior, ecology, and evolution. More specific information about the major can be found under For Prospective Students and links found there. The School also offers an IB Honors concentration for superior students seeking an extraordinary education. If you are interested in IB Honors you should see an IB Advisor as soon as possible in your freshman year.

Biochemistry at Illinois is an advanced, interdisciplinary field that encompasses the biological and chemical sciences. Our department is part of the School of Molecular and Cellular Biology and has close ties with the School of Chemical Sciences, the Institute for Genomic Biology, the Center for Biophysics and Computational Biology, the Neuroscience Program, the Medical Scholars Program, and other interdisciplinary groups. A bachelor's degree in biochemistry from the University of Illinois at Urbana-Champaign prepares students for entry into graduate programs in biochemistry, chemistry, molecular biology, or other areas of advanced biology. It will also prepare them for entry into medical, dental, veterinary, or pharmacy school. By majoring in biochemistry at Illinois students are well-prepared to enter positions in the biotechnology, chemical, and pharmaceutical industries.

Recommended high school coursework includes 4 years each of English, Mathematics, Social Sciences, Lab Sciences, and a single Foreign Language.

Undergraduate tuition: $11,847/ year in-state; $27,219/year out-of-state. Financial aid is available in the form of scholarships, grants, loans, and work-study.

Graduate Programs:
Graduate education in the School of Molecular and Cellular Biology (MCB) is focused at the departmental level: after spending the first semester doing three research rotations, students will formally join both a thesis lab and one of our four degree granting departments. Specific departmental requirements are provided under each department's heading on this Web site. Formal application is made to the School of Molecular and Cellular Biology.

Graduate studies in MCB are offered through the Departments of Biochemistry, Cell and Developmental Biology, Microbiology, and Molecular and Integrative Physiology, along with interdisciplinary programs in the Center for Biophysics and Computational Biology, the Neuroscience Program, and Medical Scholars Program. These provide an exceptionally broad range of training and research opportunities. The Department of Biochemistry at Illinois offers unique opportunities for graduate students to become skilled and creative biochemists and molecular biologists. Outstanding resources in the Department of Biochemistry include internationally recognized faculty, graduate students, and research facilities. The graduate program not only allows research students to learn the latest techniques, but also fosters their development as independent scientists.

The Department of Microbiology is a part of the School of Molecular and Cellular Biology (MCB), which includes the Departments of Biochemistry, Cell and Developmental Biology, and Molecular and Integrative Physiology. The department is part of an umbrella program in MCB that encompasses 80 different research laboratories. Students admitted into any of these departmental graduate programs can select faculty thesis advisors from over 60 active research laboratories in the school. Close ties are also maintained with the School of Integrative Biology, the School of Chemical Sciences, the College of Medicine, and the College of Veterinary Medicine.

The School of Integrative Biology comprises three departments that offer graduate degrees. The departments are animal biology, entomology, and plant biology.

Graduate tuition: $12,993/year in-state; $25,221/year out-of-state. Students accepted into the MCB Ph.D. program receive financial support through fellowships, traineeships, or graduate assistantships, which provide a generous stipend as well as a full tuition and partial fee waiver. Departments guarantee financial support to students as long as they are making satisfactory progress toward the Ph.D. degree. Several fellowships are awarded on a competitive basis to outstanding applicants. Upper-level graduate students are generally supported by research assistantships or interdisciplinary training grants. Students are recommended for training grant funding by their graduate program.


Statistics:
Applied - 28,751
Admitted - 19,434 - 68%
Enrolled total - 7,252
Full Time: - 7,249
Part Time - 3

Standards:
Test - 25th % - 75th %
SAT Reading - 540 - 660
SAT Math - 690 - 780
SAT Writing - 590 - 680
ACT Composite - 26 - 31
ACT English - 26 - 32
ACT Math - 26 - 33
ACT Writing - 8 - 9

Retention / Graduation:
Retention rate - 93%
4-year graduation rate - 65%
6-year graduation rate - 83%

Other Information:
17 Colleges and Instructional units
$583,754,000 Spending on research and development in science and engineering in 2012.
100% of all classrooms have wireless access.
360 buildings on- and off-campus have wireless access.
$29.4 million initiative implementing increased community access to high-speed fiber-optic Internet and developing community-wide Intranet with special federal and state funding.
320 Main campus buildings, 2.8 square miles (1,783 acres).
647 Total buildings, 7.1 square miles (4,552 acres).
32,281 Students from 50 states.
6,914 New freshmen enrolled in fall 2012; roughly 32,000 apply annually.
4,447 International undergraduate students.
5,000+ courses offered; more than 150 programs of study.

Undergraduate Programs and Majors:
Integrative Biology (BS)
Molecular and Cellular Biology (BS)
Biochemistry (BS)

Graduate Programs:
Biochemistry (PhD)
Cell and Developmental Biology (PhD)
Microbiology (PhD)
Molecular and Integrative Physiology (PhD)
Integrative Biology (PhD)

Dual Degree Programs:
MD/PhD
DVM/PhD


Application Deadlines:
Undergraduate: January 2nd
Graduate: Varies based on program

Applications are available online: http://admissions.illinois.edu/apply/app.html

CAMPUS VIDEO:

Bausch and Lomb is one of the leading brands in eye care products founded in the year 1853. It is an American based company that has its headquarters in Rochester, New York. The firm develops and manufactures products for eye care and eye diseases such as contact lenses, lens implants, medications and lens care products. The company has its business spread across 36 countries and has about 13, 000 employees.

Bausch and Lomb was primarily a public company that was listed in NYSE until 2006; thereafter it was acquired by private firm Warburg Pincus PLC in the year 2007.



Popular biotech products
Bausch and Lomb manufacture innovative products for eye care and also develop products for treatment of various eye diseases. The firm’s major expertise is in the area of developing a wide variety of contact lenses that suits several eye types. Below is a list of products developed by the firm:
• Contact lenses for far sightedness, near sightedness, astigmatism and presbyopia.
• Contact lenses for cataract surgery- the brand name is SilSoft which is a specially designed lens that can be used for both children as well as adults. These lenses can be used in situations when intraocular lens cannot be fitted. In majority of the cases, this type of contact lens is the only cure for infantile aphakia.
• Customized soft contact lenses indicated in individuals with keratoconus and irregularly shaped corneas.
• Bausch and Lomb also offer vision shaping treatment, which is a process that corrects the vision of an individual while they are asleep.
In addition to the above mentioned products, the firm also develops several eye vitamins, eye wash, surgical products, vision accessories, safety and industrial cleaning products, pharmaceutical products, products for dry eyes and allergies.

Latest discoveries
Bausch and Lomb is committed to improvise its existing products as well as develop new ones for treating several eye conditions. Of late, the firm launched the first ever vitamin and mineral supplement that is indicated in conditions of age related diseases. This supplement is known to match the standards and formulae as laid down in the National Eye Institute’s Age – Related Eye Disease Study 2 (AREDS2).

Recent company takeovers
Baush and Lomb recognize the importance of collaborations and partnering with various other firms to research and develop new products. Collaborations not only helps widen the areas of research but also helps expand the business prospects.
In the year 2013, the firm joined hands with THERAPEARL to market the novel mask developed by the parent company for providing relief from various types of eye diseases.
In the same year, the firm acquired Options for licensing its new compounds that have been developed for marketing products indicated for treating conditions of dry eyes.

Recent corporate news
In the year 2013, August 5, Valeant Pharmaceuticals International Inc. completed the acquisition of Bausch and Lomb. The name of the firm will however not be changed, and would function as an independent division of Valeant. With this acquisition the ophthalmic division and business of Valeant will get merged with that of Bausch and Lomb and will see a rise in net revenue of more than $ 3.5 billion.
Work culture
The work culture at Bosch and Lomb is very positive and at the same time dynamic. The employees of this firm have the potential of carrying out excellent quality research and do not leave any stone unturned for achievement of the impossible tasks.

Interesting events
The firm with its ever striving attitude to achieve something new is always ready with some innovative solutions for eye care every year. This keeps the firm in the limelight always. The Health Canada Medical device provided license to Bausch and Lomb in this year for VICTUS femtosecond laser platform.
The firm also contributes generously by providing grants to charitable organizations with the mission of helping individuals with eye diseases to have a clearer vision.

Recent job openings
The firm is always on the lookout for individuals with caliber to carry out breakthrough research for developing innovative products for eye care. Bausch and Lomb is an equal opportunity employer and hire individuals irrespective of their race, sex, disability and religion. The firm also has special provisions for individuals with mental or physical disabilities. The following table speaks of the job openings along with their job ids. They can either email the concerned authority or drop their resume at the website and wait for the recruitment process.


Job description -- -- Requisition id
Senior Training Specialist -- -- 8500
Engineering I, Manufacturing -- -- 8483
Team Leader, Manufacturing -- -- 8482
MES Programmer Analyst - Rochester, NY -- -- 8469
MES Programmer Analyst - Rochester, NY -- -- 8469
Manufacturing Supervisor, Filling -Weekend Crew -- -- 8466
Filling machine, technician -- -- 8550
Manager Medical Marketing -- -- 8247
Ocular Specialty Representative -- -- 8545
Quality Associate II -- -- 8536
Quality Inspector  -- -- 8543
Lens maker -- -- 8535
Trainer associate II -- -- 8533
Vision care – Territory manager -- -- 8542
Custodian -- -- 8540
Director marketing -- -- 8537
Ocular specialty Rep -- -- 8539
Ocular specialty representative, WI -- -- 8538
Vision care – area sales director -- -- 8520
Vision care – territory manager -- -- 8534
Vision care – sales associate -- -- 8529
Vision Care: Territory Manager - Syracuse, NY -- -- 8494
Ocular Specialty Representative - Indianapolis North (Team-Blue) -- -- 8531
Validation Engineer II -- -- 8525
Ocular Specialty Representative - West Palm Beach FL (Team Blue) -- -- 8530
Production Technician - Pegsus -- -- 8526
Vision Care: Territory Manager - Fort Worth -- -- 8523
Vision Care: Territory Manager - Cedar Rapids, IA -- -- 8518
Ocular Specialty Representative - Birmingham North (White Team) -- -- 8510
Quality Inspector - 1st -- -- 8505
Vision Care: Territory Manager - Alpharetta / Lawrenceville, GA -- -- 8495
Ocular Specialty Representative - Philadelphia, PA (Team White) -- -- 8484
Engineering Controls Technician -- -- 8079
Quality Supervisor, Microbiology -- -- 8472
Ocular Specialty Representative - Washington DC(Team-Blue 1) -- -- 8478
Manufacturing Supervisor, Technical -- -- 8464
MES Programmer Analyst - Greenville, SC -- -- 8453
Surgical: Regional Business Director - Texas -- -- 8071
Surgical: Crystalens Territory Manager: Michigan/Ohio -- -- 8456
Ocular Specialty Representative - Queens, NY (Team White) -- -- 8442
Technician IV, R&D Operations -- -- 8438
Senior Engineer, Systems (Optics Development) -- -- 8407
Canada Customer Service Representative - French -- -- 8397
Surgical Territory Manager - Charlotte, NC -- -- 8392
Production Associate III - Senior Setup Technician -- -- 8076
Senior Engineer, Packaging -- -- 8347
Sr. Equipment Engineer -- -- 8212
Surgical Associate Territory Manager/Northern Virginia -- -- 8289
Manager, Biostatistics (Vision Care R&D) -- -- 8145
Manufacturing Associate I -- -- 8047

Mylan is a generic and pharmaceutical company, serving over 140 countries and territories. It develops and manufactures products for life threatening disease conditions such as AIDS. It is one of the leading manufacturers of API which is indicated for making generic antiretroviral (ARV) therapies for treating HIV/AIDS.

One of the most basic and important principles of this firm is to market the drugs at a low cost. This had made possible treating HIV / AIDS amongst those communities where affording the medicine was really difficult. Making available the drugs at low cost has helped about one third of all the individuals receiving treatment for HIV/AIDS.

The firm has basically 3 functional areas namely: generics, active pharmaceutical ingredients and medical devices. Mylan laboratories have its business spread overseas in North America, Europe, Middle East, Asia Pacific and Africa. It is a member of NASDAQ and is traded as MYL.

Popular biotech products
Mylan laboratories is one of the largest producer of API that is used in a variety of categories such as agents in central nervous system, anti histamines, anti asthmatics, anti vials, anti diabetics, anti fungal and proton pump inhibitors. The API is also made use of in drugs for pain management.

Latest discoveries
Apart from being the leading producer of API, the firm also has hands on expertise in manufacturing generic antiretroviral (ARV) products. These products help in the treatment of people with HIV / AIDS. Mylan laboratories also develop finished products of ARVs and pediatric therapies. The firm is also on its way of developing and manufacturing newer methods and therapies for combating deadly and life threatening diseases like AIDS.

Recent company takeovers
Collaborations and partnerships with several firms have always been of benefit to both parties. It allows them to expand their research areas which also have a direct impact on the business revenues. Mylan laboratories and world team tennis joined hands in the year 2011 for a period of 3 years and signed an agreement that would serve as a title sponsor for WTT. Pfizer and Mylan also entered into a collaboration in the year 2012 that would witness the growth of generics in Japan. This collaboration will produce about 350 marketed products along with 125 products that will include wide range of therapeutic areas.

Work culture
The work culture at Mylan laboratories is very positive and they believe in team work. The employees of this firm have the capacity to even move mountains if required. They are hard working and leave no stone unturned to furnish out the best therapies for treating life threatening disease conditions. The workforce of this company are mission oriented – they believe in service, service to the world by delivering the best medical devices and therapeutics for the world at large.

Interesting events
Mylan laboratories with their hard work and consistent efforts have always been in the public eye. They have tried very hard to make impossible tasks possible. The following are some of the interesting events for the year 2013 showcasing the skills of the firm.
• The firm announced the STALEVO and TARCEVA settlement agreement.
• The firm got approval for Buproprion hydrochloride extended release tablets.
• The firm announced the completion of transdermal patch facility expansion project.
• The firm will address the gathering at the Bank of America Merill Lynch Global Healthcare Conference and Morgan Stanley Global Healthcare Unplugged Conference on the 5th of September.
• In the month of July, Mylan launched the Generic Nor – Q.D. tablets. The same month witnessed the launch of the first generic version of trilipix capsules.
Recent job openings
The firm is always on the lookout of hardworking individuals who with perseverance and research skills can take the company to new defined avenues. Following is a list of job openings at Mylan. Each job opening has been provided with the respective id and interested individuals can apply accordingly.



Sr. no. - Job title
1 - Supervisor, QA Admin
2 - IT provider commercial portfolio lead
3 - Scientist, Chemistry
4 - Supervisor
5 - Quality assurance in process supervisor
6 - Lead specialist, business process owner, manufacturing
7 - Senior IT project manager
8 - Director Global operations finance
9 - Senior director, manufacturing solutions
10 - Validation analyst
11 - Director, NA compensation and benefits
12 - Senior site core developer
13 - Executive assistant
14 - Senior QMS software engineer
15 - HRIS analyst
16 - Manager, global finance
17 - Chemist
18 - Senior director, partnering finance programs
19 - Director, global benefits
20 - senior director, sales training
21 - Finance Technology Business Analysis Principal
22 - Global R&D Operational Project Manager
23 - 2014 Summer Finance Internships
24 - Administrative Manager
25 - Scientist
26 - Administrative assistant
27 - Technical area lead
28 - Senior Manager, Advertising Promotions, Regulatory Affairs
29 - Scientist, quality
30 - Manager, Global Quality Compliance SWAT
31 - Weekend Master Mechanic
32 - Senior Accounting Assistant
33 - Engineer, Global IT Infrastructure Services
34 - Quality Assurance Supervisor
35 - Senior Associate, Pricing and Contracts
36 - Supervisor, Production Maintenance
37 - Scientist
38 - Regulatory Affairs Specialist CMC
39 - Administrative Assistant
40 - QA Review Associate, 2nd 
41 - Legal Secretary - Legal Operations
42 - Senior Review Chemist
43 - Product Safety Specialist
44 - Senior Product Safety Specialist
45 - Technical Group Leader, NA R&D Technical Services
46 - Clerk, Sorting & Scanning
47 - Internal Audit Staff
48 - Associate, Regulatory Affairs
49 - Senior Scientist


Interested candidates can drop in their resume at the company’s website clearly mentioning the post they wish to apply for along with the job id. Candidates are also advised to search and take a short tour of the company’s website to know in detail about the company and its functioning. In addition to the above mentioned job openings, individuals can also search for other jobs opportunities with this firm and place their application accordingly. They can either fill an online application form or can email the concerned authority.

Basic Information:
Yale's roots can be traced back to the 1640s, when colonial clergymen led an effort to establish a college in New Haven to preserve the tradition of European liberal education in the New World. This vision was fulfilled in 1701, when the charter was granted for a school “wherein Youth may be instructed in the Arts and Sciences [and] through the blessing of Almighty God may be fitted for Publick employment both in Church and Civil State.” In 1718 the school was renamed “Yale College” in gratitude to the Welsh merchant Elihu Yale, who had donated the proceeds from the sale of nine bales of goods together with 417 books and a portrait of King George I.

Yale College survived the American Revolutionary War (1775–1783) intact and, by the end of its first hundred years, had grown rapidly. The nineteenth and twentieth centuries brought the establishment of the graduate and professional schools that would make Yale a true university. The Yale School of Medicine was chartered in 1810, followed by the Divinity School in 1822, the Law School in 1824, and the Graduate School of Arts and Sciences in 1847 (which, in 1861, awarded the first Ph.D. in the United States), followed by the schools of Art in 1869, Music in 1894, Forestry & Environmental Studies in 1900, Nursing in 1923, Drama in 1955, Architecture in 1972, and Management in 1974.

Undergraduate Programs:
The undergraduate Molecular Biophysics and Biochemistry degree programs at Yale University are well suited for students planning to attend medical school or graduate studies in biochemistry, molecular biology, genetics, genomics, or biophysics. The MB&B major differs from the programs offered by the Molecular, Cellular, and Developmental Biology (MCDB) department in that MB&B places its central focus on studying biology using the tools of chemistry, physics, and biochemistry. MB&B students thus carry out more in-depth coursework in these areas, and typically take less coursework in other areas such as organismal biology, cell biology, and genetics.

The departments of Ecology and Evolutionary Biology (EEB) and Molecular, Cellular & Developmental Biology (MCDB) offer the major in biology jointly. Each department offers an area of concentration within the major that reflects its perspectives and approaches to research while allowing students flexibility in drawing electives from both departments. There are also two interdisciplinary tracks - in biotechnology and neurobiology - offered within the MCDB area of concentration. The major offers B.A., B.S., intensive B.S., and combined B.S./M.S. programs, the latter two for students who wish to devote more time to research.

Upper level undergraduate students in Biomedical Engineering select from classroom experiences in engineering, biology, and medicine and are introduced to independent research projects through one or more semester-long “Special Projects,” which are designed together with faculty advisors. Juniors will take core courses on the fundamentals of Biomedical Engineering, focused on mathematical modeling of transport processes and physiological systems. They will also take a full-year laboratory covering a number of current topics in the field. In addition, students will take at least three courses in a particular track (biomedical imaging, biomechanics, and biomolecular engineering), as well as a Senior Seminar to give them a broader perspective of the fields. Finally, it is important to note that as part of their Senior (Special) Project, Yale Biomedical Engineering students will select from research projects that combine Engineering and clinical medicine to address a range of important problems with direct impact on human health care.

Undergraduates must submit test scores from either the SAT and any two subject tests; or the ACT plus writing test. There are no score cutoffs for standardized tests, and successful candidates present a wide range of test results. During the most recent year, test score ranges (25th to 75th percentiles) for enrolled freshman were:

SAT-Verbal: 710-800
SAT-Math: 710-790
SAT-Writing: 720-800
ACT: 32-35

Graduate Programs:
The Yale Combined Program in the Biological and Biomedical Sciences (BBS) is a doctoral program that enables you to take advantage of all of the resources found at a modern research university. Everything Yale has to offer – faculty, facilities, and campuses - is here in one comprehensive, interdisciplinary graduate program. Tracks in the Biological and Biomedical Sciences program include: Biochemistry, Biophysics, and Structural Biology; Computational Biology and Bioinformatics; Immunology; Microbiology; Molecular Cell Biology, Genetics, and Development; Molecular Medicine, Pharmacology, and Physiology; and Neuroscience. BBS has no boundaries, either departmental or geographical. Upon admission to Yale you will have access to courses, seminars, and faculty labs in every department. Because Yale is unusual among major universities in having its main campus and medical school within walking distance of one another, you can easily participate in research activities and courses on the main University campus as well as at the world-renowned Yale School of Medicine. Moreover, Yale’s brand new West Campus is connected to the rest of the university by non-stop shuttle service.

The Biomedical Engineering graduate program started in 2000 and immediately became a popular area of study. Doctoral studies in Biomedical Engineering consist of two years of course work and of original research. The PhD program has a teaching requirement, and therefore English speaking proficiency is a requirement. The TOEFL test is required for applicants with a Bachelor’s degree from a university where English is not the primary language of instruction. It is common for incoming PhD students to score 100 or higher on the TOEFL test overall and 26 or higher on the TOEFLSpeaking test, or 7 or higher on the IELTS. PhD candidates in BME have their tuition paid and receive a stipend for living expenses (~$2500 per month). Funding comes from the University for the first year, followed by support from the primary mentor, unless the student brings his/her own funding.

Doctoral students with a concentration in Biostatistics are prepared for conducting the following types of research in health or medicine: the design of comprehensive investigations; the novel employment of existing statistical methods to address meaningful scientific questions; the development of new statistical methodologies with immediate application to studies of the cause or treatment of disease. Applicants should have knowledge of the principles of biology and a strong undergraduate record in mathematics, including course work in advanced calculus and linear algebra. A master’s degree is not required to apply for this program. Since 1999 the Department of Biostatistics has also offered an MS in Biostatistics designed to train students to meet the growing need in managed care organizations, medical research, and the pharmaceutical industry for graduates with technical skills in data analysis. As opposed to the more general MPH degree, the MS degree, now known as the MS in Public Health in the Biostatistics track, emphasizes the mastery of biostatistical skills from the beginning of the plan of study. Graduates of this program may apply to the PhD degree program.



Other Information:
Undergraduates: 5,349 (2012)
Ranking: #3 National University (2012)
Acceptance rate: 7.70% (2012)
Tuition: $42,300 USD (2012)

Undergraduate Programs and Majors:
Molecular Biophysics and Biochemistry (BS)
Biology (BS)
Biomedical Engineering (BS)

Graduate Programs:
Biological and Biomedical Sciences (PhD)
Molecular Biophysics and Biochemistry
Biomedical Engineering (MS/PhD)
Biostatistics (MS/PhD)
Physiology (MS/PhD)
Genetics (MS/PhD)
Immunology (MS/PhD)
Microbial Pathology (MS/PhD)

Application Information:
To be accepted to study at Yale, interested applicants must apply directly to the school, college, or program where the degree will be awarded: Yale College for undergraduate degrees; the Graduate School of Arts and Sciences for doctoral programs and some master’s degrees; or one of the professional schools.

Undergraduate deadline: November 1st, single-choice early admission; December 31st, regular admission

Graduate deadline: December 1st

Basic Information:
The University of South Florida is a high-impact, global research university located in beautiful Tampa Bay on Florida's spectacular west coast. It is one of the largest public universities in the nation, and among the top 50 universities, public or private, for federal research expenditures. The university is one of only four Florida public universities classified by the Carnegie Foundation for the Advancement of Teaching in the top tier of research universities, a distinction attained by only 2.3 percent of all universities.

With over 230 degree programs at the undergraduate, graduate, specialty and doctoral levels, including the doctor of medicine, there's something for everyone at USF. The university offers a dynamic learning environment that inspires innovation, creativity and collaboration and is focused on student success. More than 2,000 distinguished scholars, researchers and expert teachers, nearly all holding PhDs or the highest degrees in their fields, make up the USF faculty – including the 2012 U.S. Professor of the Year.

At USF Tampa, over 30,400 undergraduates, more than 8,400 graduates, over 550 Doctor of Medicine candidates and more than 1,500 non-degree-seeking students make up the total campus enrollment of over 41,000. The students are a diverse group, coming from every state, every U.S. territory and more than 150 countries around the world. International students make up 5 percent of the total student population.
Students at USF Tampa, are high academic achievers. New freshmen for the Fall 2012 semester had an average high school GPA of 3.94, an average SAT score of 1209, and average ACT score of 27. Fifty percent of new freshmen graduated in the top 20 percent of their class, and 86 percent are Bright Futures Scholarship recipients. Twenty-five students in the 2012 freshman class are National Merit Scholars, four are National Achievement Scholars and 15 are National Hispanic Scholars.
The university's faculty are world-class scholars. Instructional faculty at USF Tampa number more than 1,500. Eighty-six percent of full-time faculty hold terminal degrees in their field. The university has 50 endowed chairs and 30 endowed professorships.



Undergraduate Programs:
The school of biological sciences at the University of South Florida offers undergraduate degrees through two divisions, the division of Cell Biology, Microbiology and Molecular Biology and the division of Integrative Biology. The Department of Cell Biology, Microbiology and Molecular Biology (CMMB) has responsibility for the education of undergraduate students in core cell biology, molecular biology, genetics and microbiology topics as well as more specialized areas that require detailed knowledge of these subjects. To accomplish this mission, CMMB offers curricula that will lead to Bachelor of Science degrees in Biology and Microbiology. Courses are designed to meet the needs to students majoring in other science disciplines as well as non-science areas. The CMMB faculty members are dedicated to excellence in this mission.

Research and teaching in the Cell Biology, Microbiology and Molecular Biology division emphasizes cellular processes in prokaryotes and eukaryotes with an increasing focus on biotechnology and preparing students for professional careers in the areas of cell biology, microbiology and molecular Biology. Faculty research interests include: Molecular pathogenicity and antibiotic resistance of microbes; structural and computational biology; the biology of aging, gene expression and genomic instability.

Research and teaching in the Integrative Biology Division emphasizes organismal interactions and adaptations to the environment. We take a modern interdisciplinary approach to understand the interactions at many levels from cells to organisms to populations to communities to landscapes. Faculty research interests include: marine and freshwater ecology; restoration ecology; population ecology; plant-animal interactions; community ecology; plant systematics; conservation biology; ecotoxicology; biomechanics and functional morphology; environmental microbiology; microbial physiology; and gene transfer.

The department of chemistry offers a bachelor’s degree in biomedical sciences. Biomedical Sciences is designed to fulfill many of the admissions requirements for professional schools in the Health Sciences (e.g. Medicine, Pharmacy, Dentistry). Students contemplating graduate study should pursue a major in the discipline of their interest, such as Biology, Chemistry, or Microbiology.

Undergraduate Tuition: $211.19/credit hour resident; $575.01/non-resident. Financial aid is available in the form of grants, scholarships, and loans. Students should complete the FAFSA to be eligible for financial aid.

Graduate Programs:
The Department of Cell Biology, Microbiology, and Molecular Biology offers master’s degrees and doctoral degrees in Cell and Molecular Biology. The master’s degree can either be thesis based or non-thesis based. They also offer a non-thesis based master’s degree in microbiology through the department.

The Biomedical Engineering Initiative represents a joint venture between the College of Medicine and College or Engineering. This initiative is a natural extension of the current biomedical engineering expertise present at USF, and will serve and enhance the development of the large cluster of more about 300 businesses that manufacture medical products in the region. The Initiative is designed to leverage the strengths of the region's related enterprise to create innovative and novel solutions, technologies and products that address current societal needs and improve the quality of life for Florida's citizens.

The M.S. pre-professional program in Medical Sciences, within the College of Medicine, has been developed to provide a novel interdisciplinary and concentrated program of study that is designed for students interested in either future doctoral or professional programs in the biomedical sciences and who value the interdisciplinary approach. The program integrates several disciplines and topics including the subject areas of anatomy, biochemistry, genetics, histology, microbiology, neuroscience, pathology, pharmacology and physiology. These medically-oriented subject areas have been integrated to provide a solid foundation in the medical sciences. The rigorous program is designed to allow students to demonstrate their full academic ability and suitability for future careers in healthcare in either academic or clinical environments. The interdisciplinary nature of the program promotes a broad intellectual focus that is required of current and future health-care professionals. In addition to the typical subject matter, the majority of the courses integrate modern teaching methods with extensive student participation designed to improve their written, oral and presentation skills that are also important components of their future professional development. Graduates of the program are anticipated to continue their professional development at medical and dental schools together with a variety of other healthcare professional programs. Students in this track take selected pre-clinical medical school courses and are able to complete the requirements for a Master of Science degree in Medical Sciences within one year.

The M.S. research program in Medical Sciences, within the College of Medicine, offers several concentrations, which consists of basic/molecular science credits, with medical relevance. This program is designed to prepare students for future educational or research endeavors in graduate education or other professional programs.

Graduate Tuition: $431.43/credit hours residents; $877.17/credit hour non-residents. Graduate students are eligible for financial assistance in the form of research and teaching assistantships, as well as through fellowships.

Graduate admission requires a minimum B average for undergraduate work, as well as GRE scores, and letters of recommendation.

Undergraduate Programs and Majors:
Microbiology (BS)
Cell Biology, Microbiology, and Molecular Biology (BS)
Integrative Biology (BS)
Biomedical Science (BS)

Graduate Programs:
Cell and Molecular Biology (MS/PhD)
Microbiology (MS)
Biomedical Engineering (PhD)
Medical Science (PhD)
Bioinformatics (MS)
Biotechnology (MS)
Bioethics (MS)
One-year Medical Masters (MS)

Dual Degree Programs:
MD/PhD



Application Deadlines:
Undergraduate: Accepted on a rolling basis beginning in October
Graduate: Varies by program; fellowship deadline February 1st
Apply online at: https://secure.vzcollegeapp.com/usf/default.aspx?cid=87&ltid=1

Celera Corporation, founded in the year 1998, is a firm devoted to health care business. Molecular diagnostic products are developed and manufactured by this company to be used by the clinical laboratories and hospitals to detect, manage and treat disease conditions. The firm has joined hands with Abbott Laboratories for distribution and commercialization of various molecular diagnostic products developed by it.

In the year 1998, the firm was a business unit of Applera. From there it grew up to be an independent company in the year 2008. Three years hence, the company was finally acquired by Quest Diagnostics in 2011.
It is a member of NASDAQ and is traded under the name of CRA.

Popular biotech products
Celera Corporation develops products for treatment of infectious diseases such as HIV. One of its popular products in this regard is the ViroSeq HIV-1 genotyping system that is meant for detecting HIV genomic mutations. This product has also been proved to be useful for managing patients with HIV-1 in whom the drug therapies have failed to show the desired effect.

The next most effective product is a diagnostic device developed for diagnosing the genotyping assay in cystic fibrosis. This device is named as the cystic fibrosis genotyping assay. This innovative device can also be used as a new born screening tool, career screening in adults of reproductive age group and as a confirmatory diagnostic tool in children and newborns.

The AlleSEQR HLA PCR/sequencing kits and AlleSEQR Heterozygous Ambiguity Resolution Primers are developed to provide high resolution identification of human alleles.

Latest discoveries
The Celera Corporation is constantly making new discoveries in the area of both diagnostic tools as well as pharmaceutical products. The firm carries out deep studies in several disease areas such as coronary heart disease, thrombosis, lung disease, liver diseases, CNS, breast cancer, stroke and autoimmune disorders.

Recent company takeovers
Celera Corporation is ever ready to partner with several other firms for expanding their business which would in a way also help widen their areas of research. The company invites those firms that wish to partner for a long term relationship and also those who are interested in great scientific research and positive patient outcomes. Interested firms can contact them at Alliancemanagement@Celera.com for a prosperous and long term future with Celera Corporation.

Work culture
The work culture at Celera Corporation is vibrant and offers very positive environs for its employees. The company is a powerhouse of passionate individuals who can go to any extent to deliver the best diagnostic tools and pharmaceutical products to the world. Not just this, the company also rewards its employees for their excellent performance at work both financially as well as securing their future through several beneficial packages.

Interesting events
Celera Corporation has joined hands with Abbott laboratories for marketing Celera’s CE – marked KIF6 diagnostic test kit. This diagnostic test kit will detect the genetic marker that is associated with individuals who are at a risk of falling prey to coronary heart diseases.
Celera Corporation has signed a license agreement with the University of California and has given rights to conduct in – house test for the KIF6 gene test kit in their laboratories. It would be the first time that such a test will be performed outside the Corporation.

Recent job openings
Celera Corporation is always on the lookout for individuals who with their research skills can take the company to new avenues. Job openings are available and individuals need to apply for the specific job based on their experience and educational qualifications. A job id has been provided against all the jobs and the individuals need to apply accordingly. Below is a list of recent job openings.



Job title | Location
Rep, Phlebotomy Services - position in client office in Goldsboro | 1006a W H Smith Blvd
Analyst, Workforce - NOC- Tampa, FL | 4225 E Fowler Avenue
Rep, Client Service I - Lenexa, KS | 10101 Renner Blvd
Rep Phlebotomy Service - CA | 15 Altarinda Rd
Route Service Rep - Gainesville, FL - M-F 11am-7:30pm (2nd shift) | 825 NorthWest 23rd Ave.
Technician, Medical II - in client office position located at our Cary facility | 201 Commonwealth Ct
Rep, Phlebotomy Service - in client office position located in Columbia area | 3010 Farrow Road
Group Lead, Phlebotomy Service | 14050 Town Loop Blvd
Floater, Phlebotomy Service - covers the Winston-Salem Patient Services territory | 3726 Vest Mill Road
Rep, Phlebotomy Services - in client office position located in the Cumming area | Multiple Locations
Rep, Phlebotomy Svcs - Part-Time 25 hours/week - Winter Springs, FL | 1132 E. State Road 434
Analyst, Workforce - NOC - Lenexa, KS | 10101 Renner Blvd
Rep, Phlebotomy Services | 750 W Plymouth Ave
Rep, Phlebotomy Services (30 hr position) | 4509-009 St. Johns Avenue
Rep, Route Service - Miramar, FL - 2nd shift - Mon-Sat | 10200 Commerce Parkway
Rep, Phlebotomy Service - in client office position located in St Simmons area | 6555 Abercorn St
Mgr, Reporting Administration & Development - Collegeville, PA | Collegeville Main
Senior Database Administrator | MedPlus REMOTE - Nationwide
Hospital Account Executive - Washington, DC | 1901 Sulphur Spring Road
Oncology Account Manager - Orlando, FL | 541 E.Horatio Ave
Accounting Intern - MedPlus | 4690 Parkway Drive
Senior Database Administrator | MedPlus REMOTE - Nationwide
Rep, Phlebotomy Services II, West Mifflin PA area, MTh 4a-12:30p, T,W,F 6a-12:30p, plus rota Sat | 1907 Lebanon Church Road
Rep, Phlebotomy Svcs I - CA | 1600 Creekside Drive
Technician, Specimen I, Night Shift 8:30pm -5am, M-F - 40hrs/week | 875 Greentree Rd
Rep, Phlebotomy Services II, Tonawanda NY area, F/T 38hrs/wk, M-F 7:00a-2:30p, plus rot Sat 7a-12p | 2173 Sheridan Dr
Rep, Phlebotomy Services - Norman, OK | 950 N. Porter
Clinical Lab Supv - Hematology (nights) - Miramar, FL | 10200 Commerce Parkway
Rep, Route Service I - TEMPORARY (Teterboro, NJ) | One Malcolm Ave
Rep, Phlebotomy Svcs I - CA | 450 Kings County Dr
Floater, Phlebotomy Svcs - CA | 919 N Blackstone St
Rep, Phlebotomy Svcs II - (P/T), Norton OH area, 20hrs/wk, M-F(9a-1p) | 2451 Edison Blvd
Rep, Phlebotomy Svcs I - CA | 919 N Blackstone St
Asst, Pre-Analytical I, NIGHTS - M-F 10pm-6:30am, plus rotating Saturdays | 875 Greentree Rd
Route Service Rep - Part-Time 25 hrs/wk - M-F 10am-3pm | 592 Ellis Rd.
Rep, Cust Svce - 9am-6pm Tampa | 3011 University Center Drive

Genentech Inc. is a biotechnological firm that was founded in the year 1976. This company is also known as the Genetic Engineering technology and its founder is Robert A. Swanson, a venture capitalist and Dr. Herbert Boyer, who is a biochemist. Herbert Boyer is believed to have initiated the recombinant DNA technology.

Genentech Inc has been a member of the Roche group since the year 2009.

Popular biotech products
Genentech Inc. takes into consideration the human genetic information for development of therapeutic products for treatment of life threatening disease conditions. The following is a list of biotech products developed by this firm:
• Actemra
• Activase
• Anaprox
• Avastin
• Boniva injection
• Boniva tablets
• Cathflo activase
• CellCept
• Cytovene
• EC-Naprosyn
• Erivedge
• Fuzeon
• Herceptin
• Invirase
• Kadcyla
• Klonopin
• Kytril injection
• Lucentis
• Naprosyn
• Nutropin AQ
• Pegasys
• Perjeta
• Pulmozyme
• Rituxan
• Rocephin
• Roferon
• Romazicon
• Tamiflu
• Tarceva
• TNKase
• Valcyte
• Valium
• Xeloda
• Xenical
• Xolair
• Zelboraf
• Zenapax

Latest discoveries
Genentech Inc. develops products for severe medical disease conditions. The following is a comprehensive list of molecules that has been developed by the firm.
• AKT inhibitor for treatment of gastric cancer, prostate cancer and solid tumors.
• Anti CD22 and Anti – CD79b antibody drug conjugate indicated in conditions of hematologic malignancies, Non- Hodgkin’s lymphoma and diffuse large β – cell lymphoma.
• Anti – ETBR antibody drug conjugate indicated in treatment of melanoma.
• Anti-HER3/EGFR DAF MAb indicated in treatment of colorectal cancer, head and neck cancer and metastatic epithelial cells.
• Anti-PDL1for treating solid tumors and metastatic melanoma.
• Anti – STEAP 1 antibody drug conjugate for treating prostate cancer.
• Antibody drug conjugate for treatment of multiple myeloma, pancreatic and ovarian cancers.
• Crenezumab for Alzheimer’s disease
• Ocrelizumab for relapsing and progressive multiple sclerosis
• Rontalizumab for systemic lupus erythematosus
• Tofoglifozin for type 2 diabetes
• Mew molecular entity for infectious disease, cytomegalovirus disease in kidney transplant cases
• Ranimizumab for age related macular degeneration
• Anti – PCSK9 indicated for cardiovascular diseases.

Recent company takeovers
Genentech Inc. believes in partnering with organizations for expanding their business which in a way helps widening their areas of research. The firm’s relationship with Roche is a unique one. These two firms have two independent R&D organizations and with separate budget allocations.
The firm collaborates with other organizations to conduct research in the areas of immunology, cardiovascular disease, oncology, neuroscience, ophthalmic disease, therapeutic lead discovery technologies and biomarker assay technologies.

Apart from these, the firm has partnered with the following organizations:
• Array Biopharma Inc
• Seattle Genetics ADC technology
• Abbott laboratories
• Exelixis
• Piramed Ltd.
• NovImmune
• AC Immune SA

Work culture
The work culture at Genentech Inc. is very vibrant and at the same time positive. The firm regards its employees as its success pillars and considers them as assets. Its employees are appreciated and handsomely rewarded for their achievements and success. It has several benefit programs to financially secure their employees after retirement.
The employees of this firm are very hard working and leave no stone unturned for churning out products that would help fight life threatening disease. The employees strive very hard to develop therapeutic products that will be beneficial for the world at large.

Interesting events
Genentech Inc. with its constant research and breakthrough technologies is always in the limelight. The following is the list of events that would confirm the above mentioned statement.
• The drug Obnituzumab developed by Genentech was found to be much more effective than Rituxan in decreasing the disease progression in individuals with blood cancer.
• The FDA has given the go ahead for priority review of Obnituzumab for patients who have not been treated for CLL – Chronic Lymphocytic leukemia.
• The FDA has also granted permission for priority review of the drug Perjeta Regimen to be used before surgery in patients with HER2 – positive early stage breast cancer.
• The drug Avastin along with chemotherapy showed to improve the survival rate in women suffering from advanced stage of cervical cancer.
• The firm announces the phase III results of Avastin. This drug is administered to patients with aggressive forms of brain cancer. It is proposed to be given in conjunction with either chemotherapy or radiotherapy.



Recent job openings
The firm is always on the hunt for dynamic and experienced individuals who would take the firm to new higher avenues. As of now there are about 459 job openings in this firm. Listing all the openings will be difficult and therefore a few of the latest job openings have been given below. For more information interested candidates can log on to the company’s website and can also drop in their resume @genentechjobs.
• CCM manager / Senior manager, manufacturing Bioprocess: The individual would be solely responsible for handling the team and execution of the tasks. They are also responsible for executing 24 x 7 large scale media preparation and cell culture operations. Interested candidates need to have at least 9 years of experience in operations and 5 years of experience in leadership and management positions.
• Scientist – Protein analytical chemistry: The individuals are responsible for analytical characterization of recombinant proteins. The individuals also need to be an active participant in project teams and may also have to handle 2 - 4 research associates. The individual need to be doctorate in analytical chemistry, biochemistry and chemical engineering.
• Senior principle technical manager, external quality validation, steriles (Brazil): Individuals have to provide oversight validation and also assess validation of methodologies at CMPs. They need to have a graduation degree and have experience of at least 7 – 10 years in quality or validation. They should also possess strong knowledge of the global pharmaceutical and biotechnology industry.
• QC Associate II – Biological technologies: These individuals should have a graduate degree in BA or B.S and should possess strong communication skills. They should also have expertise in handling HPLC and additional knowledge in analytical technologies would be an advantage.

Basic Information:
Founded in 1829, Rochester Institute of Technology is a privately endowed, coeducational university with nine colleges emphasizing career education and experiential learning. The campus occupies 1,300 acres in suburban Rochester, the third-largest city in New York state. RIT also has international campuses in Eastern Europe and Dubai. The RIT student body consists of approximately 15,000 undergraduate and 2,900 graduate students. Enrolled students represent all 50 states and more than 100 countries.

RIT is an internationally recognized leader in preparing deaf and hard-of-hearing students for successful careers in professional and technical fields. The university provides unparalleled access and support services for the more than 1,300 deaf and hard-of-hearing students who live, study, and work with hearing students on the RIT campus.

Undergraduate Programs:
In the College of Science, biology is something that students do, rather than something they merely learn. The courses present biology as it is done by career biologists, and they emphasize hands-on laboratory and field experience. Scientific knowledge is based on research, and we encourage students to undertake research projects in the laboratories of our faculty. The biology program prepares students for rewarding positions in occupations related to the life sciences, including biomedical research, scientific management, science journalism, forensic science, ecology and environmental science, agriculture, genetic counseling, and education. The program includes all of the course work and support services to prepare students for entrance into schools of medicine, dentistry, veterinary medicine, optometry, podiatry, and chiropractic medicine. Graduates are well-prepared to pursue a master’s or doctoral degree in a wide variety of fields in the life sciences.

The Bachelor of Science degree in Biomedical Sciences consists of a Life Sciences Core combined with a broad range of flexible elective options. The Life Sciences Core is designed to provide the student with a strong grounding in mathematics and science with a complement of liberal arts in preparation for a particular career path, e.g., for entry into medical/dental school, into graduate studies, or directly into a research position in an applied area of biomedical science.

Bioinformatics lies at the interface of cutting edge science and next-generation technology, enabling discoveries that were unattainable only a few years ago. Bioinformaticists analyze the massive data sets coming out of modern biological experiments such as Next Generation Sequencing, Proteomics, Metabolomics, and Ecoinformatics. Despite occupying this vital position, formal opportunities for education in Bioinformatics are limited. Those programs that do exist are challenging because they require students to achieve a deep understanding of both the biological processes being studied and the computational approaches needed for data analysis. Nevertheless, in the supportive environment provided by the Thomas H. Gosnell School of Life Sciences at RIT, our highly motivated students thrive in their studies and go on to attend top ranked graduate schools or enter the workforce in pivotal discovery positions in the pharmaceutical, vaccine development and academic research communities.

Students who enroll in the biochemistry major often have an interest in combining the life and health sciences with a chemistry degree. Students take a year of general biology, in addition to a typical chemistry curriculum. During the upper-level years, students take a substantial core of courses in biochemistry, physical chemistry, liberal arts, and elective courses in life sciences. Students must take a minimum of two upper-division biology electives. Employment opportunities for biochemistry graduates exist in the chemical, pharmaceutical, agricultural, forensic, and rapidly expanding biotechnological fields. Graduates also are well-prepared to enter advanced degree programs in biochemistry, medicine, pharmacy, dentistry, and veterinary medicine.

The BS degree in biotechnology and molecular bioscience prepares students to immediately assume challenging positions in research, development, and management in biotechnology. Students are also well-prepared for positions in the fields of plant biotechnology, human genetics, agriculture, food products, pharmaceuticals and vaccine development, environment and energy, forensic science, and genetic counseling. The advanced nature of the third- and fourth-year courses, as well as the opportunity to participate in faculty-sponsored undergraduate research, provides a sound foundation to those graduates wishing to pursue a master’s or doctoral degree. The program also can be designed to include the education necessary for the pursuit of a career in a medical field. Specialized areas of emphasis include recombinant DNA, microbial and plant genetic engineering, mammalian and plant tissue culture, monoclonal antibody production and purification, large-scale fermentation techniques (bacterial and mammalian cell), and methods for characterization and separation of proteins and nucleic acids in yeast, bacterial, viral, and plant systems.
Undergraduate tuition: $31,584/year. cc

Graduate Programs:
RIT’s graduate program in Medical Illustration is one of only five such programs in North America and the only program in the Northeastern U.S.. The two-year program combines training in human anatomy (with complete cadaver dissection), histology (the cellular structure of organs), and pathophysiology (the study of disease) with extensive training in 2D and 3D digital graphics, interactive media, and animation. Illustration projects are designed for use in print, projection, broadcast media, and distribution via the web and mobile devices. The program emphasizes visual problem solving, determining the best approach to communicate a difficult concept. Students also gain real world experience collaborating with medical researchers and observing live surgery in the operating room. The program culminates with the production of a thesis project, which requires extensive background research and an original body of artwork on a complex medical topic.

The master of science degree in bioinformatics provides students with a strong foundation in biotechnology, computer programming, computational mathematics, statistics, and database management. Graduates of the program are well-prepared for careers in the biotechnology, bioinformatics, pharmaceutical, and vaccine industries. Based on consultation with individuals within the industry nationwide, the job market is rich with opportunities for those who obtain a graduate degree in bioinformatics, particularly when coupled with industry-sponsored research as thesis work. This research provides exposure to real-world problems—and their solutions—not otherwise attainable in an academic setting. The program provides students with the capability to enter the bioinformatics workforce and become leaders in the field. The curriculum is designed to fulfill the needs of students with diverse educational and professional backgrounds. Individuals entering an MS program in bioinformatics typically have degrees in biology, biotechnology, chemistry, statistics, computer science, information technology, or a related field. The program is offered on a full- or part-time basis to fulfill the needs of traditional students and those currently employed in the field. Admission requires a bachelor’s degree, GRE scores, letters of recommendation, and a personal statement.
Graduate tuition: $34,659/year. Financial aid is available in the form of grants, scholarships, and loans.



Statistics:
Applied 15,806
Admitted 9,266 59%
Enrolled total 2,678
Full Time: 2,669
Part Time 9
Standards:
Test 25th % 75th %
SAT Reading 530 650
SAT Math 570 680
SAT Writing 520 630
ACT Composite 25 30
ACT English 0 0
ACT Math 0 0
ACT Writing 0 0

Undergraduate Programs and Majors:
Biomedical Sciences (BS)
Biology
Biotechnology & Molecular Bioscience
Biotechnology & Molecular Bioscience with Bioinformatics Option
Bioinformatics
Environmental Science
Biochemistry

Graduate Programs:
Medical Illustration
Bioinformatics (MS)

Dual Degree Programs:
Biology or Biotechnology with MBA (BS and MBA)
Bioinformatics 4+1 BS and MS



Application Deadlines:
Undergraduate: December 1st, early decision; February 1st, regular decision. Application available at: http://www.rit.edu/emcs/admissions/apply...plication
Graduate: February 15th. Application available at: http://www.rit.edu/emcs/ptgrad/grad_admission.php

Basic Information:
Brigham Young University seeks to develop students of faith, intellect and character who have the skills and the desire to continue learning and to serve others throughout their lives. Established in 1875, the university provides an outstanding education in an atmosphere consistent with the ideals and principles of its sponsor, The Church of Jesus Christ of Latter-day Saints.



Undergraduate Programs:
The Biology major major provides students with current understanding of the full breadth of biology. The course of study is comprehensive and integrates knowledge across molecular, cellular, organismal, and ecological levels of organization. Students that earn this degree come to understand the biological world in its broadest sense. This degree focuses on understanding the diversity of life, emphasizing whole organism biology in ecological and evolutionary contexts.

The Bioinformatics undergraduate major at Brigham Young University is an interdisciplinary program offering substantial training in both the biological sciences and the physical and mathematical sciences; our program emphasizes the integration of computer science with genetics and molecular biology. A foundation in mathematics and statistics provides the basis for acquiring computer programming, data basing, and operating system skills. Students attracted to this program have dual interests in computer science and biology and find it an excellent choice for their broad interests. Students who complete this program either enter the top graduate programs in bioinformatics and computational biology in the world, enter leading professional schools (including law school, medical school, or dental school), or find employment in biotechnology, pharmaceutical, or software development companies.

A major in microbiology offers preparation for continued education or for immediate employment. Microbiology is the preferred degree for students who desire an advanced degree (MS or PhD) in microbiology, virology, immunology, parasitology or cell biology. It is also a helpful degree for students who are planning to attend medical or dental school, because of the breadth of the exposure of medical relevance. Graduates are qualified to enter the workforce with government agencies, institutes, or industry (biotech, cosmetic, food and water protection, health care, hospital, or pharmaceutical, etc.).

The Molecular Biology major includes core classes in chemistry, biology, and molecular biology as well as classes in physics and math. Lab research experience is an especially beneficial element of the program. This experience can also open opportunities to present papers and contribute to publications. Elective courses include topics in plant genetics and breeding, biochemistry, nutritional science, microbiology and human biology.

The College of Life Sciences at Brigham Young University offers an undergraduate degree in Neuroscience. The Neuroscience programs at Brigham Young University provide excellent interdisciplinary training in the classroom as well as experience in laboratory research settings for both graduate and undergraduate students. The Neuroscience Center at BYU was established in the Summer of 1999. While it was once necessary for students to apply to become a neuroscience major, that is no longer the case. Now, students interested in studying neuroscience simply need to go to the Life Sciences Advisement Center to meet with an adviser and declare a neuroscience major.

Undergraduate tuition: $2425/semester for members of the Church of Latter-Day Saints; $4850/semester for non-members. Financial assistance is available in the form of scholarships, grants, and loans. Students should complete the FAFSA to be eligible for financial aid.

Graduate Programs:
The primary goal of the doctoral program in the Biology Department is to provide advanced training in ecology and evolutionary biology, and experience in biology teaching. The program features an exciting range of subdisciplines, including evolutionary ecology, bioinformatics, systematics and phylogenetics, population, community, and ecosystem biology, and conservation. original research and teaching are emphasized to prepare students for careers in academics, and leadership positions in government or industrial settings. Faculty members do research in a variety of freshwater, marine, and terrestrial environments on several continents across a broad spectrum of taxa (vascular plants, nematodes, crustaceans, insects, fishes, amphibians, reptiles, and mammals). Doctoral research frequently combines field work with computational and laboratory work. The program is enhanced by excellent on-campus resources including: a natural history museum with extensive collections, state-of-the-art gene sequencing facilities, a controlled-environment laboratory facility, electron microscopy, herbarium, and greenhouse. The program provides a scholarly setting designed to fit the individual goals of students.

Rapid advances in molecular research techniques and new ways of thinking about biological networks and interactions have made this an exciting time to work in the biomedical sciences. The Department of Microbiology and Molecular Biology (MMBIO) represents the best BYU has to offer in the way of advanced classroom instruction and cutting-edge research. MMBIO faculty members come from excellent and diverse training backgrounds, with research emphases ranging from host-microbe interactions and pathogen detection, to DNA packaging and metabolic sensing. MMBIO graduate students have remarkable opportunities to learn current research methods and drive the discovery process.

Course work and research that emphasize the integration of molecular biology, developmental biology, biophysics, neuroanatomy, neurophysiology, neuroendocrinology, neuroimmunology, cognition, and behavioral neuroscience is offered through this PhD degree program. Students are required to develop a strong background in the principles of neuroscience and develop the intellectual background and technical expertise necessary for successful research projects in their area of specialization. Eventual publication of the research in peer-reviewed journals is expected but not required. A sound understanding of current concepts in neuroscience is the purpose of the MS degree program. The thesis research project teaches the fundamentals of scientific inquiry and trains students in state-of-the-art research techniques. Submission of the thesis to a peer-reviewed journal is encouraged but not required.
Graduate programs in the department of Physiology and Developmental Biology offer research training and classroom instruction in a wide range of areas pertaining to these disciplines. A biophysics research group is also part of the department. Areas of research include neuroendocrinology and reproduction, endocrine and immune interactions, development of the central nervous system, hereditary connective tissue disorders, mouse and chick models of development, exercise physiology and glucose metabolism, membrane transport and channel structure, synaptic vesicle recycling, and blood pressure control by the autonomic nervous system.

Admission to graduate programs at BYU requires a bachelor’s degree, GRE scores, statement of intent, and letters of recommendation.

Graduate tuition: $3065/semester for members of the Church of Latter-Day Saints; $6130/semester for non-members. PhD students are eligible for assistance in the form of teaching and research assistantships, as well as tuition and health care reimbursement. All students are eligible for scholarships and loans.

Statistics:
Applied 11,238
Admitted 7,055 63%
Enrolled total 5,624
Full Time: 5,545
Part Time 79

Standards:
Test 25th % 75th %
SAT Reading 570 680
SAT Math 580 680
SAT Writing 540 650
ACT Composite 26 30
ACT English 26 32
ACT Math 25 31
ACT Writing 0 0

Retention / Graduation:
Retention rate 87%
4-year graduation rate 30%
6-year graduation rate 77%

Undergraduate Programs and Majors:
Bioinformatics (BS)
Biological Science Education (BS)
Biology (BS)
Conservation Biology (BS)
Microbiology (BS)
Molecular Biology (BS)
Neuroscience (BS)
Physiology and Developmental Biology (BS)

Graduate Programs:
Biological Science Education (MS)
Biology (MS/PhD)
Microbiology (MS/PhD)
Molecular biology (MS/PhD)
Neuroscience (MS/PhD)
Physiology and Developmental Biology (MS/PhD)




Application Deadlines:
Undergraduate: December 1st, early admission; February 1st, regular admission. Applications can be completed online at: http://besmart.com/
Graduate: December 15th for early consideration; all applications are due by February 15th. Applications can be completed online at: http://graduatestudies.byu.edu/

Caprion pharmaceutical was established in the year 1998 in Montreal (Canada) and mainly provides proteomics biomarker and target identification services to the world at large. Through its 10 years of integrated approach, it develops in – vitro diagnostics for diseases such as diabetes, infectious diseases, oncology and disorders related to the central nervous system. It also has developed several drug target therapies such as the oncology – cell surface targets and vaccine for various infectious diseases. It has its headquarters in Montreal, Canada.



Popular biotech products
One of its most popular biotech products in the area of target discovery is CellCarta. This is a spectrometry which is gel free and it also has label free mass. This allows comprehensive measurement of protein across huge sets of biological samples. The firm also develops various pharmacodynamic biomarkers for testing the drug efficacy, determination of drug dosage, safety aspects and mechanism of action. It also develops several disease markers for diagnostic purpose and surrogates for clinical response to therapies. Its area of expertise also lies in development of predictive biomarkers for testing the efficacy, safety and clinical outcome.

Latest discoveries
The firm has developed novel technologies of protein biomarkers that facilitate the process of decision making and clinical development. Of its latest discoveries, the company has developed shigabams for the treatment of bacterial infections caused due to shiga toxin.

Caprion pharmaceutical has active programs, mainly in 3 broad areas: infectious diseases, oncology and metabolic disease. The areas under study for infectious disease include tuberculosis, brucellosis, vaccine response and dengue. Under oncology, the firm develops products for lung cancer, breast cancer, prostate cancer and neuro - endocrine cancer. For metabolic diseases, the firm manufactures products for β – cell mass function, diabetes drug response and insulin resistance.

Recent company takeovers
Caprion pharmaceuticals has attained its success and achievements with sheer hard work and subsequent collaboration with other firms. In the year 2007, the firm joined hands with Thallion pharmaceuticals for intensifying its field to development of novel technologies for oncology and infectious diseases.

In the year 2005, the firm entered into joint collaboration with ICOS Corporation for widening its area of research. This collaboration leads to the development of therapeutic antibodies for treating cancer.
Caprion pharmaceuticals also entered into partnership with several other firms such as Abbott laboratories, Biogen Idec, AstraZeneca, Pfizer, Merk & Co and ortho clinical diagnostics.

Work culture
The work environment at Caprion pharmaceuticals is dynamic and at the same time very positive. It encourages the staff to produce new and innovative methods that would be useful for the public at large. The firm is a proud owner of a strong and dynamic team of workers.

The firm gives credit of it success and achievements to its team workers and considers them as their assets. Caprion pharmaceuticals is on the constant look out for young and dynamic individuals who can take the firm to new horizons.

Interesting events
Caprion pharmaceuticals has received several awards and recognition due to its achievements in the field of pharmacy. The following list speaks of the achievements the company has received.
• The firm has received award a 5 – year $ 12.9 million contract for conducting research in the area of infectious diseases. It has received the award by National Institute of Allergy and Infectious disease.
• It has been awarded a 3 – year contract worth $2.3 million by the CQDM for discovery and validation of biomarkers.
• In collaboration with Takeda the firm is carrying out a program for identification of proteins that has been secreted from visceral and abdominal fat.
• The firm is also conducting a neuro – endocrine tumor program. This program is carried out in partnership with INCI. It is receiving funds from CQDM and Alsace – Bio valley. This program would primarily focus on discovery as well as validation of biomarkers for neuro – endocrine cancers.

Recent job openings
The firm is forever on the hunt for individuals who are logical and analytical in their thinking. The following is a list discussing about the various areas of expertise required by Caprion pharmaceuticals.
1. Controller: In this, the individual will have to prepare reports and support the development, implementation as well as the maintenance of the necessary procedures. Applications for this position would require individuals to have more than 10 years of experience and preferably be a chartered accountant.
2. Scientific director: The individual is in a way representative of both the business and scientific aspects of the firm. They would handle the overseas operations and conduct research as and when required. For applying as a scientific director, the individuals need to be doctorate in immunology and should have more than 10 years of experience.
3. Bioinformatics specialist: Individuals need to have experience in the field of bioinformatics, flow cytometry and proteomics. They are also responsible for documentation of work flows and implementation of quality control measures as well. For applying for the post of bioinformatics specialist, the individuals need to have experience in programming language such as C, C++ and Java. They also need to effectively use SQL and ORACLE.
4. Biosample operations manager: The individual is responsible for organizing and maintaining a detailed orientation of all the operational activities concerned with collection, shipment and delivery of biosamples. They need to have a degree in DEC and should have experience in site qualification, lab manual writing and working with LIMS. The candidate should also be able to communicate effectively, have influential skills, and have experience with Microsoft excel.
5. Flow cytometry technician: The individual is responsible for ensuring that the technical systems in the cytometry laboratory are working efficiently and accurately. They also need to maintain a proper documentation of the cytometry lab reports. For applying to the post of flow cytometry technician, the individual should have experience in the field of cytometry and should possess knowledge of LSR II and Diva software. The individual should also have an expertise in solving both hardware and software related problems of cytomtery. It is also necessary, that the individual should be able to handle and work efficiently under pressure.

Centocor biotech was founded in the year 1979 and is now renamed as Jassen Biotech. It is a biotechnology company that was developed with the aim of manufacturing new diagnostic assays. The year 1982 witnessed the development of the first diagnostic test product of the company which had also received FDA approval. The diagnostic test kit was used for detecting the rabies virus. In 1998, the firm sold off its diagnostic division to Fuirebio, Inc.



Popular biotech products
The firm’s first biotech product was the diagnostic test kit for testing the rabies virus. The firm also markets the product ReoPro that is indicated for treatment of coronary angiography.

Another drug known as Remicade developed by Centocor is indicated in patients with plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, spondylitis, ulcerative colitis in children and ankylosing spondylitis.

Other products by this company include the following:
• Simponi Aria
• Simponi golimumab
• Stelara
• Procrit epoetin alfa – is used in treatment of anemia due to chronic kidney disease conditions.
• Doxil – is indicated for patients with cancer
• Zytiga

Latest discoveries
The firm received FDA approval in the year 2013 for Simponi aria which is used as an infusion for treating patients with rheumatoid arthritis. In the same year the firm released the drug Ibrunitib indicated for treatment of 2 β – cell malignancies.

Yet another drug named Simponi Golimumab received FDA approval on 16th of may 2013. This drug is indicated in patients with ulcerative colitis.

In the year 2012, the US FDA approved the expansion of the drug Zytiga for treatment of metastatic castration – resistant prostate cancer.

Recent company takeovers
The firm has entered into collaborations with several other firms for extending its area of research and widening the product development plant. The following is a list of the company’s acquisitions that has enabled it to take part in new research and clinical trials for development of drugs and diagnostic tools for the world at large.
• In the year 2008, the company entered into partnership with Ortho Biotech Inc, and thus gave birth to Centocor Ortho Biotech, Inc.
• The year 2010, Centocor Ortho Biotech joined hands with RespiVert. This merger opened new avenues for development of small molecule drugs and inhalation therapies for treatment of pulmonary diseases.
• It was in the month of June, 2011, that the company was rechristened as Jassen Biotech, Inc due to its global merger with Janssen Pharmaceutical Companies.

Recent corporate news
Centocor was acquired by Johnson and Johnson which raised the company’s annual sales from $500 million to much more than $2 billion. This acquisition, also caused increase in the investment in research and development from $75 million to $300 million.
In addition, in the year 2000, the Dutch plant of this firm saw an expansion with an investment of about $250 million. In the year 2007, the Centocor introduced its first very own advertising film known as Innerstate for marketing the drug Remicade.

Work culture
The work culture at Centocor is very professional and at the same time quite friendly. The company considers its employees as its assets and rewards them for their hard work and achievements. Employees love to work in such an environment. They work very hard to develop innovative drug therapies for treating deadly disease conditions.

Interesting events
Since the time of its inception each year has been a successful year for Centocor Inc. The firm has several achievements to its credit through its constant research and development. The year 2013 has been an eventful year for the drug IBRUNITAB. The following is a list of interesting events of the company:
• In the year 2013, the research results on the drug Ibrutinab were published in the New England Journal of Medicine. The results revealed that this drug was 68% effective when given to patients with relapsed or refractory mantle cell lymphoma.
• In the same year, the firm released the phase II data of Ibrunitab. The drug was found to be effective against relapsed or refractory mantle cell or diffuse large β – cell lymphoma.
• Richer Petty joined hands with the firm for launching the prostate cancer awareness program.
• The drug ibrunitab received designations from the U.S. Food and Drug administration for third breakthrough in the field of oncology.
• The follow up data for the drug Zytiga shows that this drug is successful in delaying the progression of metastatic castration – resistant prostate cancer in patients who have received chemotherapy as part of the treatment regime.
• The firm submits reports for approval of Stelera in the US and Europe. This drug is indicated for treatment of active psoriatic arthritis.
• The firm released its phase III findings of the drug Stelera in the year 2012. The results revealed that this drug significantly decreased the symptoms of active psoriatic arthritis.
• In the year 2012, Centocor released the phase III findings of the drug intravenous glomimumab. This drug is indicated in conditions of active rheumatoid arthritis and significantly inhibited the radiographic progression in these patients.
• The firm Centocor announced the development and commercialization of JAK inhibitor for immunological diseases.

Recent job openings
The firm has a powerhouse of experienced professionals, but at the same time more and more people are required to carry the good work forward. For more information, individuals can visit the website and keep an eye on the vacancies section. If any vacancies related advertisement is spotted they can drop in their resume and wait for their screening process. The recruitment of experienced candidates is an on-going process.

For students who wish to work with this firm must have a full time degree program and should have received any of these degrees – BA, BS, MA, MS, PhD in the past 1 year. Centocor seeks vibrant and passionate individuals who are willing to work hard and are eager to achieve something in their career. Students are recruited only during selected months of the year – August and November. But, those who wish to apply for an internship program can apply during the months of December and February.

Alexion pharmaceuticals is a biopharmaceutical firm founded in the year 1992, aimed at developing innovative drugs for treatment of severe, deadly and rare disorders. The scientists of Alexion were the first to unlock the terminal component of a group of proteins that plays a vital role in the body’s immune system. These proteins if not controlled can even lead to destruction of healthy tissues.

The first product developed by this firm was Soliris. This product is indicated in treatment of paroxysmal nocturnal hemoglobinuria (PNH) and the drug is approved in more than 40 countries. Alexion pharmaceuticals has it’s headquarter in Cheshire, Connecticut.



Popular biotech products
Soliris (eculizumab) is the drug meant for treating patients with paroxysmal nocturnal hemoglobinuria (PHN). This drug has received FDA approval and is the first of its kind to unblock the terminal component of proteins. PHN is characterized by hemolysis – rapid destruction of red blood cells. It is a life threatening and progressive disease that can cause damage to the body’s vital organs such as kidneys and heart. The major and acute complications of this disease include kidney failure, heart attack and ultimately death.

The work Soliris is basically target – based. It works by attacking that part of the protein cascade which if activated in the wrong manner can give rise to a series of reactions inside the body that can lead to PHN.

Recent company takeovers
The firm has acquired its success and achievements through hard work and through mergers and acquisitions with various firms. Mergers and acquisitions with various companies allows the parent company to expand its area of research and in a way widen its drug development work.
The firm’s first acquisition was in the year 2000, when it joined hands with Proliferon Inc., another biopharmaceutical firm at $ 41 million. This firm was then renamed as Alexion Antibody Technologies Inc. Proliferon firm could produce indefinite amount of antibodies which was the major reason of its acquisition by Alexion Pharmaceuticals.

In the year 2011, Alexion entered into a merger with Enobia Pharma Corporation at $610 million which was paid at the time of merger. Later on a sum of $470 million was to be paid as contingent on company sales. The firm Enobia developed drug known as asfotase alfa which is used for treating genetic disorders such as hypophosphatasia.

Recent corporate news
Alexion became the member of NASDAQ – 100 in the year 2011. In the same year it had market value of $ 8.5 billion due to which it replaced the Genzyme Corporation.

Work culture
Alexion is an equal opportunity employer. The work culture in this firm is very positive and vibrant. The company is on the constant look out for individuals who would carry their firm to newer heights.

The firm provides a variety of benefits for its employees. The benefits include employee assistance program, tuition assistance, flexible spending accounts, 529 college savings plan, insurance for automobile and homeowners, prescription drug coverage, 410 (K) plan and long term disability plan.

Interesting events
The firm Alexion is constantly in the limelight due its constant efforts to bring out the best drugs through great research work. Its work has been acclaimed due to its wonder discoveries that have made possible the treatment of severe life threatening diseases.
The year 2013 has been an eventful year for Alexion pharmaceuticals. The following is the list of events that have taken place for this firm:
• The firm announced its second quarter results in this year.
• This wonder drug – Soliris received positive opinion from the Committee for Orphan medicinal products for the treatment of NMO. The drug Soliris also received the title of “Orphan drug”.
The year 2012 was also a year of real achievement for Alexion pharmaceuticals. It was in this year, that the firm was honored with the title of “Biotech’s New Innovation Powerhouse”. In the same year the firm received the second rank in the annual list of “The World’s Most Innovative Companies”.

Recent job openings
The company is on a hunt for young, committed, experienced and dynamic individuals who with their research skills and hard work can take their firm to new, unfathomable heights. The current positions available include marketing, clinical development, research, support functions and manufacturing. Interested candidates are asked to investigate the company’s website and look out for the job vacancies. The following is a list of job opportunities for the candidates:
Job opportunities in Birmingham
• Regional account manager
Job opportunities in Cambridge
• Associate director
• Manager
• Medical director
• Senior financial analysts
• Senior statistical programmer
• Manager regulatory liaison
Job opportunities in Cheshire, CT
• Associate director – corporate communications, corporate GxP audit, drug product manufacturing, global clinical supply, global medical value assessment, sourcing, regulatory affairs, non clinical PK/PD/DM.
• Director regional clinical specialist
• Customer operations representative
• Data integration engineer
• Developmental scientist
• Director us marketing
• Director internal audit, internal communications, global hematology marketing.
• HR systems administrator
• Manager, corporate quality
• Manager, internal audit, regulatory liaison, regulatory operations.
• Research associate
• Research scientists – molecular sciences, protein sciences
• Senior director – global information security
• Senior manager – global market research, clinical quality assurance, hematology marketing
• Senior statistical programmer
Job opportunities in Las Vegas
• Regional accounts manager - biotechnology, oncology and hematology
Job opportunities in Orlando
• Regional accounst manager – biotechnology, oncology and hematology
Job opportunities in Providence
• Regional accounts manager – oncology, pharmaceutical sales and biotechnology
Job opportunities in Raleigh
• Regional accounts manager – oncology, hematology sales and biotechnology
Job opportunities in Smithfield
• Associate director – process automation and maintenance and building services
• Engineer I
• GMP trainer
• Maintenance and instrumentation technician
• Manufacturing associate I, II and III
• Manufacturing specialist
• QA engineer and specialist
• QC analyst I - stability, IV – technical services
• QC equipment technician
• Validation technician
• Senior quality engineer

Interested candidates can apply for the above jobs based on their educational qualification and experience in the respective fields. It is also advised that the individuals be vigilant about the job openings and should apply either through email or by posting their resume at the website. Selected candidates will be called upon for an interview and if selected will be screened for the final selection process.

Medivation is a biopharmaceutical firm committed to develop innovative therapies for treatment of serious diseases. The firm has come as a hope to individuals suffering from various diseases for which very limited treatment options are available. The firm was developed by an expert team of individuals who had previously been part of a pharmaceutical firm. Medivation was set up with the goal of development of therapies for treatment of severe illnesses and medical devices that can help early detection of diseases.

The company has its headquarters in San Francisco and has more than 300 employees. Medivation got its first product approved in the year 2012.



Popular biotech products
XTANDI is the most popular biotech product of Medivation. This drug is indicated in patients with metastatic castration – resistant prostate cancer (mCRPC). Xtandi is solely meant for men and should in no way be used by women. Pregnant women and women of child – bearing age should also refrain from using this drug.

Though the use of this drug has proved to be effective for patients with prostate cancer, but this drug has also shown to have some side effects. These include back ache, fatigue, arthralgia, hot flush, edema, musculoskeletal pain, insomnia, dizziness, hematuria, anxiety, hypertension, lower respiratory tract infection, cauda equina syndrome and paresthesia.

Xtandi works by decreasing the tumor volume, induces death of the cancer cells and arrests as well as decreases cell growth. This drug in no way causes decrease in the levels of androgen, but works by inhibiting the binding of androgen to its receptors.

Latest discoveries
The scientists at Medivation are constantly striving to create new drugs for the treatment of diseases such as prostate cancer and breast cancer. The drug Xtandi has been developed for treatment of prostate cancer. The company in partnership with Astellas is in the process of developing enzalutamide for various stages of prostate and breast cancer.

Recent company takeovers
Medivation realizes the importance of partnerships and therefore enters into collaboration with various pharmaceutical firms for widening its area of research as well as developing several therapeutic products for treating life threatening diseases like cancer. In the year 2009, the firm joined hands with Astellas to develop and market enzalutamide. The collaboration was worth $110 million. Astellas would be responsible for developing the drug and marketing it and has also agreed to pay royalty to Medivation on the aggregate net sales of enzalutamide outside US.
Several efforts are also been made to test the efficacy of enzalutamide for the more advanced stages of prostate and breast cancer.

Recent corporate news
Medivation has been a member of the NASDAQ and is traded as MDVN. The last stock price was 56.53 on the 30th of August 2013.

Work culture
Medivation considers its employees as its assets and the work environment in this firm is very fast paced and vibrant. The employees of this firm strive hard to conduct research and develop new and innovative therapies for treating deadly disease conditions. They are extremely confident and committed group of people who can take the company to new horizons. Employees at Medivation can go to any extent to serve the public at large by developing beneficial drug therapies.

Interesting events
The firm is always up for various interesting events and is an active participant in many conferences. The Morgan Stanley Global Health Conference is scheduled on the 10th of September, 2013.
Medivation has also taken part in two conferences in the month of August, 2013. These were Wedbush 2013 Life Sciences Management Access Conference and Medivation second quarter 2013 financial results conference call.

Recent job openings
Medivation is forever on the search of vibrant individuals with analytical minds who can deliver their best to the world and also are ready to undertake challenges. Interested individuals can drop in their resume and wait for the recruitment process. The following is the list of career opportunities with Medivation.

-Accounting, finance: There are several positions available in this field; such as director, tax, senior accountant, senior manager and senior financial analyst. For these positions, individuals need to have more than 10 years of experience in tax and relevant accounting. They should also have working knowledge on the several tax related subjects.
-Biometrics: The positions available are manager, clinical data manager, and senior statistical programmer. For these, the individuals need to have at least 7 – 10 years of experience in oncology studies and also have a basic knowledge of SAS.
-Clinical development: The positions in this field include clinical project manager, director of drug safety, manager of drug safety and clinical research associate. In order to apply for this position, the candidates need to undergo training in GCP and should have 2 years of experience in clinical research.
-Medical affairs: The available positions for this field include medical director and senior director of medical affairs. The individuals need to have at least 3 – 5 years of experience in pharmaceutical company and also have 2 years of experience in medical affairs. They also need to possess professional knowledge and skills in oncology.
-Medicinal chemistry: The available position for this field is associate director who are required to support the research work and the developmental activities and set goals for future work. The individuals need to have more than 6 years of experience in small molecule and drug discovery and its development.
-Pharmaceutical operations: Stability manager in pharmaceutical operations need to have at least 5 years of experience in GXP research laboratory. They also need to have experience in working with CMOs in a virtual environment.
-Pre clinical: The positions available in this field constitute of senior director, administrative assistant and associate director, and predictive diagnostics. For these positions, the individuals need to have experience that would suit each area of expertise. For applying for the post of administrative assistant, the individuals should have 5 – 7 years of experience as an administrative professional and should be an expert in operating Ms Office. For applying for the post of senior director, toxicology, the individuals should have 15 years of experience in a pharmaceutical industry and should have expertise in handling PhD level staff.

Forest laboratories is a pharmaceutical firm aimed at developing therapeutic drugs for the treatment of various kinds of diseases. Reaching out to the unreached and meeting the medical needs of the unmet is the motto of this firm.

Forest laboratories took birth in the year 1954 and has its headquarters in New York City, US. It is traded as NYSE and has more than 5,600 employees. The firm also operates from various other cities of St. Louis, Oakland, Dublin, Paris, Kent, Jersey City and Cincinnati. Forest ranks as one of the top 50 pharmaceutical companies worldwide (Pharmaceutical Executive magazine, May 2013)

"Our strategies would be without value if it were not for the thousands of employees who help to create and bring life to our company. It is due to their tenacity, skill, and hard work that we owe our success" is what the Howard Solomon Chairman, CEO & President says.

Popular Biotech products
The products developed by Forest laboratories include BISTOLIC, DALIRESP, FETZIMA, LINZESS, NAMENDA, NMAENDA XR, SAVELLA, TEFLARO, TUDORZA, PRESSAIR and VIIBRYD.

These diverse ranges of therapeutic products are meant for treating various disease conditions such as disorders of the central nervous system, respiratory, endocrinology, respiratory diseases, anti – infective therapeutics, gastrointestinal and obstetrics.

Latest discoveries
The company’s main goal is to serve the public at large by developing innovative therapeutic drugs for various disease conditions. With this motto, Forest Laboratories is constantly innovating new products and conducts 3 phases of clinical trials for testing the efficacy of these products.

The following is a list of products that have been recently developed for treating disease conditions such as various infectious diseases, pulmonary disorders, cardiovascular diseases, Alzheimer’s disease, COPD – chronic obstructive pulmonary disease and mental health disorders.
• Cariprazine for treating bipolar disease
• Bystolic valsartan for treatment of hypertension
• Tudorza for treating COPD
• Azimilide indicated for treatment of arrhythmia – irregular heart beats
• Ceftazidime for treating infectious disease conditions
• Namendra for treating Alzheimer’s disease

All the above mentioned drugs have either been approved by the NDA or have completed the phase III of clinical trials.

Recent company takeovers
Forest laboratories is a mid – sized firm that develops and markets therapeutic products covering a wide range of diseases. The firm has entered into partnerships with several other firms for expanding its business as well as widening its area of research to develop the best drugs for the world at large. Acquisitions and merger helps a firm to enter into new research areas and develop products that can be beneficial for the public.

Work culture
The work culture at Forest laboratories is pretty positive and vibrant with an enormous group of energetic employees who are ready to undertake any task with passion. With each collaboration, the firm works in a close knit fashion with its partners to make sure the end product is flawless and one of its kind. The firm considers its employees as its strength and pillars of success.

Forest laboratories also offer its employees a number of benefits that is enough for financially securing their future. These benefits include profit sharing program and the 410 (K) plans. It also has special provision for holidays and vacations for its employees so that they can take rest and recharge their minds and body for delivering the best to the company and in turn to the society at large. The firm also offers several family benefit programs that include new mom and baby programs, parental leave, adoption and fertility assistance program, so and so forth.



Interesting events
Forest laboratories is constantly striving to deliver the best therapeutic products for treatment of various disease conditions. These continuous efforts have caused them to always be in the limelight that has given them the much needed attention and success. The following is a list of interesting events for the current year - 2013.
• The firm in partnership with Almirall decides to delay the NDA filing of a drug – Aclidinium.
• Forest laboratories together with Pierre Fabre laboratories announce the FDA approval of Fetzima that is indicated for treatment of depressive disorders in adults.
• The firm reported its fiscal year first quarter 2014 diluted earnings value of $0.09 per share.
• The firm in the current year announced the positive results of the phase III clinical trial for the drug Nebivolol and valsartan in combination for treatment of hypertension.
• The current year – 2013 also witnessed the availability of new once – daily Namendra X.
• In the month of June, 2013, the firm appointed its new independent director and also provided a detailed report on the succession planning.
• In the month of May, 2013, Forest laboratories presented its data on the clinical trials of the drug Aclidinium Bromide and Roflumilast at the International conference of American Thoracic Society (ATS).

Recent job openings
Forest laboratories is open for experienced and vibrant individuals who with their hard work and research skills would take the firm to fathomable heights in the future. The interested candidates can drop in their resume at talent.acquisition@frx.com. The firm also has several provisions for seasonal internship programs for students and also for experienced professionals. Forest offers a variety of opportunities and career paths that span a broad spectrum of strengths, expertise, and interests. If you would like to build your career with a company that is consistently recognized in industry rankings as a top pharmaceutical company.
The following are the available positions for the professionals:

-Pharmaceutical Sales Representative - Palm Springs, CA (Field/Remote)
-Pharmaceutical Sales Representative - Grapevine, TX (Field/Remote)
-Associate Business Information Manager - (NJ - Jersey City)

Individuals are requested to apply with the job id mentioned on the company’s website. They can also search the careers and opportunities section in the website and click on the available and preferred positions for more details on a specific opening or position. Selected candidates will be called for an interview and will be screened as per the company’s recruitment process.

Substances that are capable of enhancing the response of the immune system to the antigen are termed as Adjuvants. They can also be substances that enhance the effect of a drug on the body. The history of Adjuvant can be traced back to 1920s, when French biologist, Gaston Ramon revealed that the response of antitoxins to tetanus and diphtheria was amplified by injection of these vaccines, along with other substances such as lecithin, agar, starch oil, saponin, and breadcrumbs. Adjuvants are mainly utilized in organisms that are used to raise antibodies by injecting the antigen. The net effect is to stimulate a larger and more prolonged generation of the antibody.